Skip to main content
Erschienen in: Clinical Pharmacokinetics 8/2004

01.07.2004 | Review Article

Drug Transfer and Metabolism by the Human Placenta

verfasst von: Michael R. Syme, James W. Paxton, Dr Jeffrey A. Keelan

Erschienen in: Clinical Pharmacokinetics | Ausgabe 8/2004

Einloggen, um Zugang zu erhalten

Abstract

The major function of the placenta is to transfer nutrients and oxygen from the mother to the foetus and to assist in the removal of waste products from the foetus to the mother. In addition, it plays an important role in the synthesis of hormones, peptides and steroids that are vital for a successful pregnancy. The placenta provides a link between the circulations of two distinct individuals but also acts as a barrier to protect the foetus from xenobiotics in the maternal blood.
However, the impression that the placenta forms an impenetrable obstacle against most drugs is now widely regarded as false. It has been shown that that nearly all drugs that are administered during pregnancy will enter, to some degree, the circulation of the foetus via passive diffusion. In addition, some drugs are pumped across the placenta by various active transporters located on both the fetal and maternal side of the trophoblast layer. It is only in recent years that the impact of active transporters such as P-glycoprotein on the disposition of drugs has been demonstrated. Facilitated diffusion appears to be a minor transfer mechanism for some drugs, and pinocytosis and phagocytosis are considered too slow to have any significant effect on fetal drug concentrations.
The extent to which drugs cross the placenta is also modulated by the actions of placental phase I and II drug-metabolising enzymes, which are present at levels that fluctuate throughout gestation. Cytochrome P450 (CYP) enzymes in particular have been well characterised in the placenta at the level of mRNA, protein, and enzyme activity. CYP1A1, 2E1, 3A4, 3A5, 3A7 and 4B1 have been detected in the term placenta. While much less is known about phase II enzymes in the placenta, some enzymes, in particular uridine diphosphate glucuronosyltransferases, have been detected and shown to have specific activity towards marker substrates, suggesting a significant role of this enzyme in placental drug detoxification.
The increasing experimental data on placental drug transfer has enabled clinicians to make better informed decisions about which drugs significantly cross the placenta and develop dosage regimens that minimise fetal exposure to potentially toxic concentrations. Indeed, the foetus has now become the object of intended drug treatment. Extensive research on the placental transfer of drugs such as digoxin and zidovudine has assisted with the safe treatment of the foetus with these drugs in utero. Improved knowledge regarding transplacental drug transfer and metabolism will result in further expansion of pharmacological treatment of fetal conditions.
Literatur
1.
Zurück zum Zitat Smith CH, Moe AJ, Ganapathy V. Nutrient transport pathways across the epithelium of the placenta. Annu Rev Nutr 1992; 12: 183–206PubMedCrossRef Smith CH, Moe AJ, Ganapathy V. Nutrient transport pathways across the epithelium of the placenta. Annu Rev Nutr 1992; 12: 183–206PubMedCrossRef
2.
Zurück zum Zitat Hahn T, Desoye G. Ontogeny of glucose transport systems in the placenta and its progenitor tissues. Early Pregnancy 1996; 2: 168–82PubMed Hahn T, Desoye G. Ontogeny of glucose transport systems in the placenta and its progenitor tissues. Early Pregnancy 1996; 2: 168–82PubMed
3.
Zurück zum Zitat Moe AJ. Placental amino acid transport. Am J Physiol 1995; 268: C1321–31PubMed Moe AJ. Placental amino acid transport. Am J Physiol 1995; 268: C1321–31PubMed
4.
Zurück zum Zitat Seeds AE. Placental transfer. In: Barnes AC, editor. Intrauterine development. Philadelphia: Lea & Febiger, 1968: 103–28 Seeds AE. Placental transfer. In: Barnes AC, editor. Intrauterine development. Philadelphia: Lea & Febiger, 1968: 103–28
5.
Zurück zum Zitat Hill MD, Abramson FP. The significance of plasma protein binding on the fetal/maternal distribution of drugs at steadystate. Clin Pharmacokinet 1988; 14: 156–70PubMedCrossRef Hill MD, Abramson FP. The significance of plasma protein binding on the fetal/maternal distribution of drugs at steadystate. Clin Pharmacokinet 1988; 14: 156–70PubMedCrossRef
6.
Zurück zum Zitat Meigs RA, Ryan KJ. Cytochrome P-450 and steroid biosynthesis in the human placenta. Biochim Biophys Acta 1968; 165: 476–82CrossRef Meigs RA, Ryan KJ. Cytochrome P-450 and steroid biosynthesis in the human placenta. Biochim Biophys Acta 1968; 165: 476–82CrossRef
7.
Zurück zum Zitat Collier AC, Ganley NA, Tingle MD, et al. UDP-glucuronosyltransferase activity, expression and cellular localization in human placenta at term. Biochem Pharmacol 2002; 63: 409–19PubMedCrossRef Collier AC, Ganley NA, Tingle MD, et al. UDP-glucuronosyltransferase activity, expression and cellular localization in human placenta at term. Biochem Pharmacol 2002; 63: 409–19PubMedCrossRef
8.
Zurück zum Zitat Pacifici GM, Rane A. Glutathione S-transferase in the human placenta at different stages in pregnancy. Drug Metab Dispos 1981; 9: 472–5PubMed Pacifici GM, Rane A. Glutathione S-transferase in the human placenta at different stages in pregnancy. Drug Metab Dispos 1981; 9: 472–5PubMed
9.
Zurück zum Zitat Pacifici GM, Rane A. Epoxide hydroxylase in human placenta at different stages in pregnancy. Dev Pharmacol Ther 1983; 6: 83–93PubMed Pacifici GM, Rane A. Epoxide hydroxylase in human placenta at different stages in pregnancy. Dev Pharmacol Ther 1983; 6: 83–93PubMed
10.
Zurück zum Zitat Pasanen M. The expression and regulation of drug metabolism in human placenta. Adv Drug Deliv Rev 1999; 38: 81–97PubMedCrossRef Pasanen M. The expression and regulation of drug metabolism in human placenta. Adv Drug Deliv Rev 1999; 38: 81–97PubMedCrossRef
11.
Zurück zum Zitat van der Aa EM, Peereboom-Stegeman JHJC, Noordhoek J, et al. Mechanisms of drug transfer across the placenta. Pharm World Sci 1998; 20: 139–48PubMedCrossRef van der Aa EM, Peereboom-Stegeman JHJC, Noordhoek J, et al. Mechanisms of drug transfer across the placenta. Pharm World Sci 1998; 20: 139–48PubMedCrossRef
12.
Zurück zum Zitat Kaufmann P, Scheffen I. Placental development. In: Polin RA, Fox WW, editors. Fetal and neonatal physiology. Philadelphia: WB Saunders, 1992: 47–56 Kaufmann P, Scheffen I. Placental development. In: Polin RA, Fox WW, editors. Fetal and neonatal physiology. Philadelphia: WB Saunders, 1992: 47–56
13.
Zurück zum Zitat Moore KL, Persaud TVN. Before we are born: essentials of embryology and birth defects, 5th edition. Philadelphia: W.B. Saunders Company, 1998 Moore KL, Persaud TVN. Before we are born: essentials of embryology and birth defects, 5th edition. Philadelphia: W.B. Saunders Company, 1998
14.
Zurück zum Zitat Enders AC, Blankenship TN. Comparative placental structure. Adv Drug Deliv Rev 1999; 38: 3–16PubMedCrossRef Enders AC, Blankenship TN. Comparative placental structure. Adv Drug Deliv Rev 1999; 38: 3–16PubMedCrossRef
15.
Zurück zum Zitat Ferm VH. The rapid detection of teratogenic activity. Lab Invest 1965; 14: 1500–5PubMed Ferm VH. The rapid detection of teratogenic activity. Lab Invest 1965; 14: 1500–5PubMed
16.
Zurück zum Zitat King CT, Howell J. Teratogenic effect of buclizine and hydroxyzine in the rat and chlorcyclizine in the mouse. Am J Obstet Gynecol 1966; 95: 109–11PubMed King CT, Howell J. Teratogenic effect of buclizine and hydroxyzine in the rat and chlorcyclizine in the mouse. Am J Obstet Gynecol 1966; 95: 109–11PubMed
17.
Zurück zum Zitat Fabro S, Smith RL. The teratogenic activity of thalidomide in the rabbit. J Pathol Bacteriol 1966; 91: 511–9PubMedCrossRef Fabro S, Smith RL. The teratogenic activity of thalidomide in the rabbit. J Pathol Bacteriol 1966; 91: 511–9PubMedCrossRef
18.
Zurück zum Zitat Rodin AE, Koller LA, Taylar JD. Association of thalidomide (Kevadon) with congenital anomalies. CMAJ 1962; 86: 744–6 Rodin AE, Koller LA, Taylar JD. Association of thalidomide (Kevadon) with congenital anomalies. CMAJ 1962; 86: 744–6
19.
Zurück zum Zitat Pacifici GM, Nottoli R. Placental transfer of drugs administered to the mother. Clin Pharmacokinet 1995; 28(3): 235–69PubMedCrossRef Pacifici GM, Nottoli R. Placental transfer of drugs administered to the mother. Clin Pharmacokinet 1995; 28(3): 235–69PubMedCrossRef
20.
Zurück zum Zitat Garland M. Pharmacology of drug transfer across the placenta. Obstet Gynecol Clin North Am 1998; 25: 21–42PubMedCrossRef Garland M. Pharmacology of drug transfer across the placenta. Obstet Gynecol Clin North Am 1998; 25: 21–42PubMedCrossRef
21.
Zurück zum Zitat Nau H. Physicochemical and structural properties regulating placental drug transfer. In: Polin RA, Fox WW, editors. Fetal and neonatal physiology. Philadelphia: WB Saunders, 1992: 130–41 Nau H. Physicochemical and structural properties regulating placental drug transfer. In: Polin RA, Fox WW, editors. Fetal and neonatal physiology. Philadelphia: WB Saunders, 1992: 130–41
22.
Zurück zum Zitat Ward RM. Drug therapy of the fetus. J Clin Pharmacol 1993; 33: 780–9PubMed Ward RM. Drug therapy of the fetus. J Clin Pharmacol 1993; 33: 780–9PubMed
23.
Zurück zum Zitat Forestier F, Daffos F, Capella-Pavlovsky M. Low molecular weight heparin (PK 10169) does not cross the placenta during the second trimester of pregnancy study by direct fetal blood sampling under ultrasound. Thromb Res 1984; 34: 557–60PubMedCrossRef Forestier F, Daffos F, Capella-Pavlovsky M. Low molecular weight heparin (PK 10169) does not cross the placenta during the second trimester of pregnancy study by direct fetal blood sampling under ultrasound. Thromb Res 1984; 34: 557–60PubMedCrossRef
24.
Zurück zum Zitat Forestier F, Daffos F, Rainaut M, et al. Low molecular weight heparin (CY 216) does not cross the placenta during the third trimester of pregnancy [letter]. Thromb Haemost 1987; 57: 234PubMed Forestier F, Daffos F, Rainaut M, et al. Low molecular weight heparin (CY 216) does not cross the placenta during the third trimester of pregnancy [letter]. Thromb Haemost 1987; 57: 234PubMed
25.
Zurück zum Zitat Omri A, Delaloye JF, Andersen H, et al. Low molecular weight heparin Novo (LHN-1) does not cross the placenta during the second trimester of pregnancy. Thromb Haemost 1989; 61: 55–6PubMed Omri A, Delaloye JF, Andersen H, et al. Low molecular weight heparin Novo (LHN-1) does not cross the placenta during the second trimester of pregnancy. Thromb Haemost 1989; 61: 55–6PubMed
26.
Zurück zum Zitat Schneider D, Heilmann L, Harenberg J. Placental transfer of low-molecular weight heparin. Geburtshilfe Frauenheilkd 1995; 55: 93–8PubMedCrossRef Schneider D, Heilmann L, Harenberg J. Placental transfer of low-molecular weight heparin. Geburtshilfe Frauenheilkd 1995; 55: 93–8PubMedCrossRef
27.
Zurück zum Zitat Dickinson RG, Fowler DW, Kluck RM. Maternofetal transfer of phenytoin, p-hydroxy-phenytoin and p-hydroxy-phenytoinglucuronide in the perfused human placenta. Clin Exp Pharmacol Physiol 1989; 16: 789–97PubMedCrossRef Dickinson RG, Fowler DW, Kluck RM. Maternofetal transfer of phenytoin, p-hydroxy-phenytoin and p-hydroxy-phenytoinglucuronide in the perfused human placenta. Clin Exp Pharmacol Physiol 1989; 16: 789–97PubMedCrossRef
28.
Zurück zum Zitat Paxton JW. α1-Acid glycoprotein and binding of basic drugs. Methods Find Exp Clin Pharmacol 1983; 5: 635–48PubMed Paxton JW. α1-Acid glycoprotein and binding of basic drugs. Methods Find Exp Clin Pharmacol 1983; 5: 635–48PubMed
29.
Zurück zum Zitat Kragh-Hansen U. Molecular aspects of ligand binding to serum albumin. Pharmacol Rev 1981; 33: 17–53PubMed Kragh-Hansen U. Molecular aspects of ligand binding to serum albumin. Pharmacol Rev 1981; 33: 17–53PubMed
30.
Zurück zum Zitat Wood M, Wood AJJ. Changes in plasma drug binding and α1-acid glycoprotein in mother and newborn infant. Clin Pharmacol Ther 1981; 29: 522–6PubMedCrossRef Wood M, Wood AJJ. Changes in plasma drug binding and α1-acid glycoprotein in mother and newborn infant. Clin Pharmacol Ther 1981; 29: 522–6PubMedCrossRef
31.
Zurück zum Zitat Thomas J, Long G, Morgan D. Plasma protein binding and placental transfer of bupivacaine. Clin Pharmacol Ther 1976; 19: 426–34PubMed Thomas J, Long G, Morgan D. Plasma protein binding and placental transfer of bupivacaine. Clin Pharmacol Ther 1976; 19: 426–34PubMed
32.
Zurück zum Zitat Herngren L, Ehrnebo M, Boréus LO. Drug binding to plasma proteins during human pregnancy and in the perinatal period: studies in cloxacillin and alprenolol. Dev Pharmacol Ther 1983; 6: 110–44PubMed Herngren L, Ehrnebo M, Boréus LO. Drug binding to plasma proteins during human pregnancy and in the perinatal period: studies in cloxacillin and alprenolol. Dev Pharmacol Ther 1983; 6: 110–44PubMed
33.
Zurück zum Zitat Krauer B, Dayer P, Anner R. Changes in serum albumin and alpha-1-acid glycoprotein concentrations during pregnancy: an analysis of fetal-maternal pairs. Br J Obstet Gynaecol 1984; 91: 875–81PubMedCrossRef Krauer B, Dayer P, Anner R. Changes in serum albumin and alpha-1-acid glycoprotein concentrations during pregnancy: an analysis of fetal-maternal pairs. Br J Obstet Gynaecol 1984; 91: 875–81PubMedCrossRef
34.
Zurück zum Zitat Hamar C, Levy G. Serum protein binding of drugs and bilirubin in newborn infants and their mothers. Clin Pharmacol Ther 1980; 28: 58–63PubMedCrossRef Hamar C, Levy G. Serum protein binding of drugs and bilirubin in newborn infants and their mothers. Clin Pharmacol Ther 1980; 28: 58–63PubMedCrossRef
35.
Zurück zum Zitat Herman NL, Li AT, Van Decar TK, et al. Transfer of methohexital across the perfused human placenta. J Clin Anesth 2000; 12: 25–30PubMedCrossRef Herman NL, Li AT, Van Decar TK, et al. Transfer of methohexital across the perfused human placenta. J Clin Anesth 2000; 12: 25–30PubMedCrossRef
36.
Zurück zum Zitat Schmolling J, Jung S, Reinsberg J, et al. Digoxin transfer across the isolated placenta is influenced by maternal and fetal albumin concentrations. Reprod Fertil Dev 1996; 8: 969–74PubMedCrossRef Schmolling J, Jung S, Reinsberg J, et al. Digoxin transfer across the isolated placenta is influenced by maternal and fetal albumin concentrations. Reprod Fertil Dev 1996; 8: 969–74PubMedCrossRef
37.
Zurück zum Zitat Tsadkin M, Holcberg G, Sapir O, et al. Albumin-dependent digoxin transfer in isolated perfused human placenta. Int J Clin Pharmacol Ther 2001; 39: 158–61PubMed Tsadkin M, Holcberg G, Sapir O, et al. Albumin-dependent digoxin transfer in isolated perfused human placenta. Int J Clin Pharmacol Ther 2001; 39: 158–61PubMed
38.
Zurück zum Zitat Wallace S. Altered plasma albumin in the newborn infant. Br J Clin Pharmacol 1977; 14: 82–5CrossRef Wallace S. Altered plasma albumin in the newborn infant. Br J Clin Pharmacol 1977; 14: 82–5CrossRef
39.
Zurück zum Zitat Krasner J, Giacoia GP, Yaffe SJ. Drug protein binding in the newborn infant. Ann N Y Acad Sci 1973; 226: 101–14PubMedCrossRef Krasner J, Giacoia GP, Yaffe SJ. Drug protein binding in the newborn infant. Ann N Y Acad Sci 1973; 226: 101–14PubMedCrossRef
40.
Zurück zum Zitat Reynolds F. Transfer of drugs. In: Chamberlain GVP, Wilkinson AW, editors. Placental transfer. Kent: Pitman Medical Publishing, 1979: 166–81 Reynolds F. Transfer of drugs. In: Chamberlain GVP, Wilkinson AW, editors. Placental transfer. Kent: Pitman Medical Publishing, 1979: 166–81
41.
Zurück zum Zitat Nau H, Luck W, Kuhnz W. Decreased serum protein binding of diazepam and its major metabolite in the neonate during the first postnatal week relate to increased free fatty acid levels. Br J Clin Pharmacol 1984; 17: 92–8PubMedCrossRef Nau H, Luck W, Kuhnz W. Decreased serum protein binding of diazepam and its major metabolite in the neonate during the first postnatal week relate to increased free fatty acid levels. Br J Clin Pharmacol 1984; 17: 92–8PubMedCrossRef
42.
Zurück zum Zitat Ridd MJ, Brown KF, Nation RL, et al. Differential transplacental binding of diazepam: causes and implications. Eur J Clin Pharmacol 1983; 24: 595–601PubMedCrossRef Ridd MJ, Brown KF, Nation RL, et al. Differential transplacental binding of diazepam: causes and implications. Eur J Clin Pharmacol 1983; 24: 595–601PubMedCrossRef
43.
Zurück zum Zitat Sastry BVR. Techniques to study human placental transport. Adv Drug Deliv Rev 1999; 38: 17–39PubMedCrossRef Sastry BVR. Techniques to study human placental transport. Adv Drug Deliv Rev 1999; 38: 17–39PubMedCrossRef
44.
Zurück zum Zitat Ala-Kokko TI, Myllynen P, Vähäkangas K. Ex vivo perfusion of the human placental cotyledon: implications for anesthetic pharmacology. Int J Obstet Anesth 2000; 9: 26–38CrossRef Ala-Kokko TI, Myllynen P, Vähäkangas K. Ex vivo perfusion of the human placental cotyledon: implications for anesthetic pharmacology. Int J Obstet Anesth 2000; 9: 26–38CrossRef
45.
Zurück zum Zitat Nanovskaya T, Deshmukh S, Brooks M, et al. Transplacental transfer and metabolism of buprenorphine. J Pharmacol Exp Ther 2002; 300: 26–33PubMedCrossRef Nanovskaya T, Deshmukh S, Brooks M, et al. Transplacental transfer and metabolism of buprenorphine. J Pharmacol Exp Ther 2002; 300: 26–33PubMedCrossRef
46.
Zurück zum Zitat Ala-Kokko TI, Pienimaki P, Herva R, et al. Transfer of lidocaine and bupivacaine across the isolated perfused human placenta. Pharmacol Toxicol 1995; 77: 142–8PubMedCrossRef Ala-Kokko TI, Pienimaki P, Herva R, et al. Transfer of lidocaine and bupivacaine across the isolated perfused human placenta. Pharmacol Toxicol 1995; 77: 142–8PubMedCrossRef
47.
Zurück zum Zitat Dancis J, Jansen V, Levitz M. Placental transfer of steroids: effect of binding to serum albumin and to placenta. Am J Physiol 1980; 238: E208–13PubMed Dancis J, Jansen V, Levitz M. Placental transfer of steroids: effect of binding to serum albumin and to placenta. Am J Physiol 1980; 238: E208–13PubMed
48.
Zurück zum Zitat Aherne W, Dunnill MS. Quantitative aspects of placental structure. J Pathol Bacteriol 1966; 91: 123–39PubMedCrossRef Aherne W, Dunnill MS. Quantitative aspects of placental structure. J Pathol Bacteriol 1966; 91: 123–39PubMedCrossRef
49.
Zurück zum Zitat de Sweet M. Embryology. In: de Sweit M, Chamberlain G, editors. Basic science of obstetrics and gynecology. Edinburgh: Churchill Livingstone, 1992: 27–52 de Sweet M. Embryology. In: de Sweit M, Chamberlain G, editors. Basic science of obstetrics and gynecology. Edinburgh: Churchill Livingstone, 1992: 27–52
50.
Zurück zum Zitat Aherne W, Dunnill MS. Morphometry of the human placenta. Br Med Bull 1966; 22: 5–8PubMed Aherne W, Dunnill MS. Morphometry of the human placenta. Br Med Bull 1966; 22: 5–8PubMed
51.
Zurück zum Zitat Reynolds F, Knott C. Pharmacokinetics in pregnancy and placental transfer. Oxf Rev Reprod Biol 1989; 11: 389–449PubMed Reynolds F, Knott C. Pharmacokinetics in pregnancy and placental transfer. Oxf Rev Reprod Biol 1989; 11: 389–449PubMed
52.
Zurück zum Zitat Bourget P, Roulot C, Fernandez H. Models for placental transfer studies of drugs. Clin Pharmacokinet 1995; 28(2): 161–80PubMedCrossRef Bourget P, Roulot C, Fernandez H. Models for placental transfer studies of drugs. Clin Pharmacokinet 1995; 28(2): 161–80PubMedCrossRef
53.
Zurück zum Zitat Gembruch U, Hansmann M, Bald R.B. Direct intrauterine fetal treatment of fetal tachyarrhythmia with severe hydrops fetalis by antiarrythmic drugs. Fetal Ther 1988; 3: 210–5PubMedCrossRef Gembruch U, Hansmann M, Bald R.B. Direct intrauterine fetal treatment of fetal tachyarrhythmia with severe hydrops fetalis by antiarrythmic drugs. Fetal Ther 1988; 3: 210–5PubMedCrossRef
54.
Zurück zum Zitat Schmolling J, Renke K, Richter O, et al. Digoxin, flecainamide, and amiodarone transfer across the placenta and the effects of an elevated umbilical venous pressure on the transfer rate. Ther Drug Monit 2000; 22: 582–8PubMedCrossRef Schmolling J, Renke K, Richter O, et al. Digoxin, flecainamide, and amiodarone transfer across the placenta and the effects of an elevated umbilical venous pressure on the transfer rate. Ther Drug Monit 2000; 22: 582–8PubMedCrossRef
55.
Zurück zum Zitat Folkart GR, Dancis J, Monye WL. Transfer of carbohydrates across guinea pig placenta. Am J Obstet Gynecol 1960; 80: 221–3PubMed Folkart GR, Dancis J, Monye WL. Transfer of carbohydrates across guinea pig placenta. Am J Obstet Gynecol 1960; 80: 221–3PubMed
56.
Zurück zum Zitat Henderson GI, Hu ZQ, Yang Y, et al. Ganciclovir transfer by human placenta and its effects on rat fetal cells. Am J Med Sci 1993; 306: 151–6PubMedCrossRef Henderson GI, Hu ZQ, Yang Y, et al. Ganciclovir transfer by human placenta and its effects on rat fetal cells. Am J Med Sci 1993; 306: 151–6PubMedCrossRef
57.
Zurück zum Zitat Kudo Y, Urabe T, Fujiwara A, et al. Carrier-mediated transport system for cephalexin in human placental brush-border membrane vesicles. Biochim Biophys Acta 1989; 978: 313–8PubMedCrossRef Kudo Y, Urabe T, Fujiwara A, et al. Carrier-mediated transport system for cephalexin in human placental brush-border membrane vesicles. Biochim Biophys Acta 1989; 978: 313–8PubMedCrossRef
58.
Zurück zum Zitat Fant ME, Yeakley J, Harrison RW. Evidence for carrier-mediated transport of glucocorticoids by human placental membrane vesicles. Biochim Biophys Acta 1983; 731: 415–20PubMedCrossRef Fant ME, Yeakley J, Harrison RW. Evidence for carrier-mediated transport of glucocorticoids by human placental membrane vesicles. Biochim Biophys Acta 1983; 731: 415–20PubMedCrossRef
59.
Zurück zum Zitat Bissonnette JM. Placental transport of carbohydrates. Mead Johnson Symp Perinat Dev Med 1981; 18: 21–3PubMed Bissonnette JM. Placental transport of carbohydrates. Mead Johnson Symp Perinat Dev Med 1981; 18: 21–3PubMed
60.
Zurück zum Zitat Ganapathy V, Prasad PD, Ganapathy ME, et al. Placental transporters relevant to drug distribution across the maternalfetal interface. J Pharmacol Exp Ther 2000; 294: 413–20PubMed Ganapathy V, Prasad PD, Ganapathy ME, et al. Placental transporters relevant to drug distribution across the maternalfetal interface. J Pharmacol Exp Ther 2000; 294: 413–20PubMed
61.
Zurück zum Zitat St-Pierre V, Ugele B, Gambling L, et al. Mechanisms of drug transfer across the human placenta: a workshop report. Placenta 2002; 23 Suppl. A: 159–64CrossRef St-Pierre V, Ugele B, Gambling L, et al. Mechanisms of drug transfer across the human placenta: a workshop report. Placenta 2002; 23 Suppl. A: 159–64CrossRef
62.
Zurück zum Zitat Gottesman MM, Hrycyna CA, Schoenlein PV, et al. Genetic analysis of the multidrug transporter. Annu Rev Genet 1995; 29: 607–49PubMedCrossRef Gottesman MM, Hrycyna CA, Schoenlein PV, et al. Genetic analysis of the multidrug transporter. Annu Rev Genet 1995; 29: 607–49PubMedCrossRef
63.
Zurück zum Zitat Gottesman M, Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 1993; 62: 385–427PubMedCrossRef Gottesman M, Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 1993; 62: 385–427PubMedCrossRef
64.
Zurück zum Zitat Huang L, Hoffman T, Vore M. Adenosine triphosphate-dependent transport of estradiol-17β-D-glucuronide in membrane vesicles by MDR1 expressed in insect cells. Hepatology 1998; 28: 1371–7PubMedCrossRef Huang L, Hoffman T, Vore M. Adenosine triphosphate-dependent transport of estradiol-17β-D-glucuronide in membrane vesicles by MDR1 expressed in insect cells. Hepatology 1998; 28: 1371–7PubMedCrossRef
65.
Zurück zum Zitat King M, Su W, Chang A, et al. Transport of opioids from the brain to the periphery by P-glycoprotein: peripheral actions of central drugs. Nat Neurosci 2001; 4: 268–74PubMedCrossRef King M, Su W, Chang A, et al. Transport of opioids from the brain to the periphery by P-glycoprotein: peripheral actions of central drugs. Nat Neurosci 2001; 4: 268–74PubMedCrossRef
66.
Zurück zum Zitat Raggers RJ, Vogels I, van Meer G. Multidrug-resistance P-glycoprotein (MDR1) secretes platelet-activating factor. Biochem J 2001; 357: 859–65PubMedCrossRef Raggers RJ, Vogels I, van Meer G. Multidrug-resistance P-glycoprotein (MDR1) secretes platelet-activating factor. Biochem J 2001; 357: 859–65PubMedCrossRef
67.
Zurück zum Zitat Kim RB, Fromm MF, Wandel C, et al. The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. J Clin Invest 1998; 101: 289–94PubMedCrossRef Kim RB, Fromm MF, Wandel C, et al. The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. J Clin Invest 1998; 101: 289–94PubMedCrossRef
68.
Zurück zum Zitat Hunter J, Jepson MA, Tsuruo T, et al. Functional expression of P-glycoprotein in apical membranes of human intestinal Caco-2 cells. Kinetics of vinblastine secretion and interaction with modulators. J Biol Chem 1993; 268: 14991–7PubMed Hunter J, Jepson MA, Tsuruo T, et al. Functional expression of P-glycoprotein in apical membranes of human intestinal Caco-2 cells. Kinetics of vinblastine secretion and interaction with modulators. J Biol Chem 1993; 268: 14991–7PubMed
69.
Zurück zum Zitat Schinkel AH, Wagenaar E, van Deemter L, et al. Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. J Clin Invest 1995; 96: 1698–705PubMedCrossRef Schinkel AH, Wagenaar E, van Deemter L, et al. Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. J Clin Invest 1995; 96: 1698–705PubMedCrossRef
70.
Zurück zum Zitat Cordon-Cardo C, O’Brien JP, Boccia J, et al. Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. J Histochem Cytochem 1990; 38: 1277–87PubMedCrossRef Cordon-Cardo C, O’Brien JP, Boccia J, et al. Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. J Histochem Cytochem 1990; 38: 1277–87PubMedCrossRef
71.
Zurück zum Zitat Sugawara I, Kataoka I, Morishita Y, et al. Tissue distribution of p-glycoprotein encoded by a multidrug-resistant gene as revealed by a monoclonal antibody, MRK 16. Cancer Res 1988; 48: 1926–9PubMed Sugawara I, Kataoka I, Morishita Y, et al. Tissue distribution of p-glycoprotein encoded by a multidrug-resistant gene as revealed by a monoclonal antibody, MRK 16. Cancer Res 1988; 48: 1926–9PubMed
72.
Zurück zum Zitat Ushigome F, Takanaga H, Matsuo H, et al. Human placental transport of vinblastine, vincristine, digoxin and progesterone: contribution of P-glycoprotein. Eur J Pharmacol 2000; 408: 1–10PubMedCrossRef Ushigome F, Takanaga H, Matsuo H, et al. Human placental transport of vinblastine, vincristine, digoxin and progesterone: contribution of P-glycoprotein. Eur J Pharmacol 2000; 408: 1–10PubMedCrossRef
73.
Zurück zum Zitat Pávek P, Fendrich Z, Staud F, et al. Influence of p-glycoprotein on the transplacental passage of cyclosporin. J Pharm Sci 2001; 10: 1583–92CrossRef Pávek P, Fendrich Z, Staud F, et al. Influence of p-glycoprotein on the transplacental passage of cyclosporin. J Pharm Sci 2001; 10: 1583–92CrossRef
74.
Zurück zum Zitat Schinkel AH, Mayer U, Wagenaar E, et al. Normal viability and altered pharmacokinetics in mice lacking mdr-1-type (drugtransporting) P-glycoproteins. Proc Natl Acad Sci U S A 1997; 94: 4028–33PubMedCrossRef Schinkel AH, Mayer U, Wagenaar E, et al. Normal viability and altered pharmacokinetics in mice lacking mdr-1-type (drugtransporting) P-glycoproteins. Proc Natl Acad Sci U S A 1997; 94: 4028–33PubMedCrossRef
75.
Zurück zum Zitat Schinkel AH, Smit JJ, van Tellingen O, et al. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 1994; 77: 491–502PubMedCrossRef Schinkel AH, Smit JJ, van Tellingen O, et al. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 1994; 77: 491–502PubMedCrossRef
76.
Zurück zum Zitat Lankas GR, Wise LD, Cartwright ME, et al. Placental P-glycoprotein deficiency enhance susceptibility to chemically induced birth defects in mice. Reprod Toxicol 1998; 12: 457–63PubMedCrossRef Lankas GR, Wise LD, Cartwright ME, et al. Placental P-glycoprotein deficiency enhance susceptibility to chemically induced birth defects in mice. Reprod Toxicol 1998; 12: 457–63PubMedCrossRef
77.
Zurück zum Zitat Smit JW, Huisman MT, van Tellingen O, et al. Absence or pharmacologcal blocking of placental P-glycoprotein profoundly increases fetal drug exposure. J Clin Invest 1999; 104: 1441–7PubMedCrossRef Smit JW, Huisman MT, van Tellingen O, et al. Absence or pharmacologcal blocking of placental P-glycoprotein profoundly increases fetal drug exposure. J Clin Invest 1999; 104: 1441–7PubMedCrossRef
78.
Zurück zum Zitat König J, Nies AT, Cui Y, et al. Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance. Biochim Biophys Acta 1999; 1461: 377–94PubMedCrossRef König J, Nies AT, Cui Y, et al. Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance. Biochim Biophys Acta 1999; 1461: 377–94PubMedCrossRef
79.
Zurück zum Zitat Borst P, Evers R, Kool M, et al. A family of drug transporters: the multidrug resistance-associated proteins. J Natl Cancer Inst 2000; 92: 1295–302PubMedCrossRef Borst P, Evers R, Kool M, et al. A family of drug transporters: the multidrug resistance-associated proteins. J Natl Cancer Inst 2000; 92: 1295–302PubMedCrossRef
80.
Zurück zum Zitat Hipfner DR, Deeley RG, Cole SPC. Structural, mechanistic and clinical aspects of MRP1. Biochim Biophys Acta 1999; 1461: 359–76PubMedCrossRef Hipfner DR, Deeley RG, Cole SPC. Structural, mechanistic and clinical aspects of MRP1. Biochim Biophys Acta 1999; 1461: 359–76PubMedCrossRef
81.
Zurück zum Zitat Cole SP, Bhardwaj G, Gerlach JH, et al. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 1992; 258: 1650–4PubMedCrossRef Cole SP, Bhardwaj G, Gerlach JH, et al. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 1992; 258: 1650–4PubMedCrossRef
82.
Zurück zum Zitat Kool M, de Haas M, Scheffer GL, et al. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1 ), in human cancer cell lines. Cancer Res 1997; 57: 3537–47PubMed Kool M, de Haas M, Scheffer GL, et al. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1 ), in human cancer cell lines. Cancer Res 1997; 57: 3537–47PubMed
83.
Zurück zum Zitat Suzuki H, Sugiyama Y. Excretion of GSSG and glutathione conjugates mediated by MRP1 and cMOAT/MRP2. Semin Liver Dis 1998; 18: 359–76PubMedCrossRef Suzuki H, Sugiyama Y. Excretion of GSSG and glutathione conjugates mediated by MRP1 and cMOAT/MRP2. Semin Liver Dis 1998; 18: 359–76PubMedCrossRef
84.
Zurück zum Zitat Gerk PM, Vore M. Regulation and expression of the multidrug resistance-associated protein 2 (MRP2) and its role in drug disposition. J Pharm Exp Ther 2002; 302: 407–15CrossRef Gerk PM, Vore M. Regulation and expression of the multidrug resistance-associated protein 2 (MRP2) and its role in drug disposition. J Pharm Exp Ther 2002; 302: 407–15CrossRef
85.
Zurück zum Zitat Sugawara I, Akiyama S, Scheper RJ, et al. Lung resistance protein (LRP) expression in human normal tissues in comparison with that of MDR1 and MRP. Cancer Lett 1997; 112: 23–31PubMedCrossRef Sugawara I, Akiyama S, Scheper RJ, et al. Lung resistance protein (LRP) expression in human normal tissues in comparison with that of MDR1 and MRP. Cancer Lett 1997; 112: 23–31PubMedCrossRef
86.
Zurück zum Zitat St-Pierre V, Serrano MA, Macias RIR, et al. Expression of members of the multidrug resistance protein family in human term placenta. Am J Physiol Regul Integr Comp Physiol 2000; 279: R1495–503PubMed St-Pierre V, Serrano MA, Macias RIR, et al. Expression of members of the multidrug resistance protein family in human term placenta. Am J Physiol Regul Integr Comp Physiol 2000; 279: R1495–503PubMed
87.
Zurück zum Zitat Flens MJ, Zaman GJR, van der Valk P, et al. Tissue distribution of the multidrug resistance protein. Am J Pathol 1996; 148: 1237–47PubMed Flens MJ, Zaman GJR, van der Valk P, et al. Tissue distribution of the multidrug resistance protein. Am J Pathol 1996; 148: 1237–47PubMed
88.
Zurück zum Zitat Cui Y, König J, Buchholz U, et al. Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells. Mol Pharmacol 1999; 55: 929–37PubMed Cui Y, König J, Buchholz U, et al. Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells. Mol Pharmacol 1999; 55: 929–37PubMed
89.
Zurück zum Zitat Allikmets R, Schriml LM, Hutchinson A, et al. A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance. Cancer Res 1998; 58: 5337–9PubMed Allikmets R, Schriml LM, Hutchinson A, et al. A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance. Cancer Res 1998; 58: 5337–9PubMed
90.
Zurück zum Zitat Allen JD, Brinkhuis RF, Wijnholds J, et al. The mouse Bcrp1/Mxr/Abcp gene: amplification and overexpression in cell lines selected for resistance to topotecan, mitoxantrone, or doxorubicin. Cancer Res 1999; 59: 4237–41PubMed Allen JD, Brinkhuis RF, Wijnholds J, et al. The mouse Bcrp1/Mxr/Abcp gene: amplification and overexpression in cell lines selected for resistance to topotecan, mitoxantrone, or doxorubicin. Cancer Res 1999; 59: 4237–41PubMed
91.
Zurück zum Zitat Jonker JW, Smit JW, Brinkhuis RF, et al. Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan. J Natl Cancer Inst 2000; 92: 1651–6PubMedCrossRef Jonker JW, Smit JW, Brinkhuis RF, et al. Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan. J Natl Cancer Inst 2000; 92: 1651–6PubMedCrossRef
92.
Zurück zum Zitat Ramamoorthy S, Leibach FH, Ganapathy V. Partial purification and characterization of the human placental serotonin transporter. Placenta 1993; 14: 449–61PubMedCrossRef Ramamoorthy S, Leibach FH, Ganapathy V. Partial purification and characterization of the human placental serotonin transporter. Placenta 1993; 14: 449–61PubMedCrossRef
93.
Zurück zum Zitat Ramamoorthy S, Prasad PD, Kulanthaivel P, et al. Expression of a cocaine-sensitive noradrenaline transporter in the human placental syncytiotrophoblast. Biochemistry 1993; 32: 1346–53PubMedCrossRef Ramamoorthy S, Prasad PD, Kulanthaivel P, et al. Expression of a cocaine-sensitive noradrenaline transporter in the human placental syncytiotrophoblast. Biochemistry 1993; 32: 1346–53PubMedCrossRef
94.
Zurück zum Zitat Kekuda R, Prasad PD, Wu X, et al. Cloning and functional characterization of a potential-sensitive, polyspecific organic cation transporter (OCT3) most abundantly expressed in placenta. J Biol Chem 1998; 273: 15971–9PubMedCrossRef Kekuda R, Prasad PD, Wu X, et al. Cloning and functional characterization of a potential-sensitive, polyspecific organic cation transporter (OCT3) most abundantly expressed in placenta. J Biol Chem 1998; 273: 15971–9PubMedCrossRef
95.
Zurück zum Zitat Ramamoorthy JD, Ramamoorthy S, Leibach FH, et al. Human placental monoamine transporters as targets for amphetamines. Am J Obstet Gynecol 1995; 173: 1782–7PubMedCrossRef Ramamoorthy JD, Ramamoorthy S, Leibach FH, et al. Human placental monoamine transporters as targets for amphetamines. Am J Obstet Gynecol 1995; 173: 1782–7PubMedCrossRef
96.
Zurück zum Zitat Shearman LP, Meyer JS. Cocaine up-regulates norepinephrine transporter binding in the rat placenta. Eur J Pharmacol 1999; 386: 1–6PubMedCrossRef Shearman LP, Meyer JS. Cocaine up-regulates norepinephrine transporter binding in the rat placenta. Eur J Pharmacol 1999; 386: 1–6PubMedCrossRef
97.
Zurück zum Zitat Kenney SP, Kekuda R, Prasad PD, et al. Cannabinoid receptors and their role in the regulation of the serotonin transporter in human placenta. Am J Obstet Gynecol 1999; 181: 491–7PubMedCrossRef Kenney SP, Kekuda R, Prasad PD, et al. Cannabinoid receptors and their role in the regulation of the serotonin transporter in human placenta. Am J Obstet Gynecol 1999; 181: 491–7PubMedCrossRef
98.
Zurück zum Zitat Wu X, Huang W, Prasad PD. Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter. J Pharmacol Exp Ther 1999; 290: 1482–92PubMed Wu X, Huang W, Prasad PD. Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter. J Pharmacol Exp Ther 1999; 290: 1482–92PubMed
99.
Zurück zum Zitat Ohashi R, Tamai I, Yabuuchi H, et al. Na+-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance. J Pharmacol Exp Ther 1999; 291: 778–84PubMed Ohashi R, Tamai I, Yabuuchi H, et al. Na+-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance. J Pharmacol Exp Ther 1999; 291: 778–84PubMed
100.
Zurück zum Zitat Wu X, Prasad PD, Leibach FH, et al. cDNA sequence, transport function, and genomic organisation of human OCTN2, a new member of the organic cation transporter family. Biochem Biophys Res Commun 1998; 246: 589–95PubMedCrossRef Wu X, Prasad PD, Leibach FH, et al. cDNA sequence, transport function, and genomic organisation of human OCTN2, a new member of the organic cation transporter family. Biochem Biophys Res Commun 1998; 246: 589–95PubMedCrossRef
101.
Zurück zum Zitat Wu X, George RL, Huang W, et al. Structural and functional characteristics and tissue distribution pattern of rat OCTN1, an organic cation transporter, cloned from placenta. Biochim Biophys Acta 2000; 1466: 315–27PubMedCrossRef Wu X, George RL, Huang W, et al. Structural and functional characteristics and tissue distribution pattern of rat OCTN1, an organic cation transporter, cloned from placenta. Biochim Biophys Acta 2000; 1466: 315–27PubMedCrossRef
102.
Zurück zum Zitat Price NT, Jakson VN, Halestrap AP. Cloning and sequencing of four new mammalian monocarboxylate transporter (MCT) homologues confirms the existence of a transporter family with an ancient past. Biochem J 1998; 329: 321–8PubMed Price NT, Jakson VN, Halestrap AP. Cloning and sequencing of four new mammalian monocarboxylate transporter (MCT) homologues confirms the existence of a transporter family with an ancient past. Biochem J 1998; 329: 321–8PubMed
103.
Zurück zum Zitat Ganapathy V, Ganapathy ME, Tiruppathi C, et al. Sodium gradient-driven, high-affinity, uphill transport of succinate in human placental brush-border membrane vesicles. Biochem J 1988; 249: 179–84PubMed Ganapathy V, Ganapathy ME, Tiruppathi C, et al. Sodium gradient-driven, high-affinity, uphill transport of succinate in human placental brush-border membrane vesicles. Biochem J 1988; 249: 179–84PubMed
104.
Zurück zum Zitat Balkovetz DF, Leibach FH, Mahesh VB, et al. A proton gradient is the driving force for the uphill transport of lactate in human placental brush-border membrane vescicles. J Biol Chem 1988; 263: 13823–30PubMed Balkovetz DF, Leibach FH, Mahesh VB, et al. A proton gradient is the driving force for the uphill transport of lactate in human placental brush-border membrane vescicles. J Biol Chem 1988; 263: 13823–30PubMed
105.
Zurück zum Zitat Poole RC, Halestrap AP. Transport of lactate and other monocarboxylates across mammalian plasma membranes. Am J Physiol 1993; 264: C761–82PubMed Poole RC, Halestrap AP. Transport of lactate and other monocarboxylates across mammalian plasma membranes. Am J Physiol 1993; 264: C761–82PubMed
106.
Zurück zum Zitat Malone FD, D’Alton ME. Drugs in pregnancy: anticonvulsants. Semin Perinatol 1997; 21: 114–23PubMedCrossRef Malone FD, D’Alton ME. Drugs in pregnancy: anticonvulsants. Semin Perinatol 1997; 21: 114–23PubMedCrossRef
107.
Zurück zum Zitat Ishizaki T, Yokochi K, Chiba K, et al. Placental transfer of anticonvulsants (phenobarbital, phenytoin, valproic acid) and the elimination from neonates. Pediatr Pharmacol 1981; 1: 291–303 Ishizaki T, Yokochi K, Chiba K, et al. Placental transfer of anticonvulsants (phenobarbital, phenytoin, valproic acid) and the elimination from neonates. Pediatr Pharmacol 1981; 1: 291–303
108.
Zurück zum Zitat Utoguchi N, Audus KL. Carrier-mediated transport of valproic acid in BeWo cells, a human trophoblast cell line. Int J Pharm 2000; 195: 115–24PubMedCrossRef Utoguchi N, Audus KL. Carrier-mediated transport of valproic acid in BeWo cells, a human trophoblast cell line. Int J Pharm 2000; 195: 115–24PubMedCrossRef
109.
Zurück zum Zitat Ushigome F, Takanaga H, Matsuo H, et al. Uptake mechanism of valproic acid in human placenta choriocarcinoma cell line (BeWo). Eur J Pharmacol 2001; 417: 169–76PubMedCrossRef Ushigome F, Takanaga H, Matsuo H, et al. Uptake mechanism of valproic acid in human placenta choriocarcinoma cell line (BeWo). Eur J Pharmacol 2001; 417: 169–76PubMedCrossRef
110.
Zurück zum Zitat Nakamura H, Ushigome F, Koyabu N, et al. Proton gradientdependent transport of valproic acid in human placental brush-border membrane vesicles. Pharm Res 2002; 19: 154–61PubMedCrossRef Nakamura H, Ushigome F, Koyabu N, et al. Proton gradientdependent transport of valproic acid in human placental brush-border membrane vesicles. Pharm Res 2002; 19: 154–61PubMedCrossRef
111.
Zurück zum Zitat Grassl SM. Human placental brush-border membrane Na+-pantothenate cotransport. J Biol Chem 1992; 267: 22902–6PubMed Grassl SM. Human placental brush-border membrane Na+-pantothenate cotransport. J Biol Chem 1992; 267: 22902–6PubMed
112.
Zurück zum Zitat Grassl SM. Human placental brush-border membrane Na+-biotin cotransport. J Biol Chem 1992; 267: 17760–5PubMed Grassl SM. Human placental brush-border membrane Na+-biotin cotransport. J Biol Chem 1992; 267: 17760–5PubMed
113.
Zurück zum Zitat Pasanen M, Pelkonen O. The expression and environmental regulation of P450 enzymes in human placenta. Crit Rev Toxicol 1994; 24: 211–29PubMedCrossRef Pasanen M, Pelkonen O. The expression and environmental regulation of P450 enzymes in human placenta. Crit Rev Toxicol 1994; 24: 211–29PubMedCrossRef
114.
Zurück zum Zitat Marray M. P450-enzymes-inhibition mechanisms, genetic regulation and effects of liver disease. Clin Pharmacokinet 1992; 23: 132–46CrossRef Marray M. P450-enzymes-inhibition mechanisms, genetic regulation and effects of liver disease. Clin Pharmacokinet 1992; 23: 132–46CrossRef
115.
Zurück zum Zitat Gonzalez FJ. The molecular biology of cytochrome P450s. Pharmacol Rev 1989; 40: 243–88 Gonzalez FJ. The molecular biology of cytochrome P450s. Pharmacol Rev 1989; 40: 243–88
116.
Zurück zum Zitat Thompson EAJ, Siiteri PK. The involvement of human placental microsomal cytochrome P-450 in aromatization. J Biol Chem 1974; 249: 5373–8PubMed Thompson EAJ, Siiteri PK. The involvement of human placental microsomal cytochrome P-450 in aromatization. J Biol Chem 1974; 249: 5373–8PubMed
117.
Zurück zum Zitat Hakkola J, Pasanen M, Hukkanen J, et al. Expression of xenobiotic-metabolising cytochrome-P450 forms in human full-term placenta. Biochem Pharmacol 1996; 51: 403–11PubMedCrossRef Hakkola J, Pasanen M, Hukkanen J, et al. Expression of xenobiotic-metabolising cytochrome-P450 forms in human full-term placenta. Biochem Pharmacol 1996; 51: 403–11PubMedCrossRef
118.
Zurück zum Zitat Hakkola J, Raunio H, Purkunen R, et al. Detection of cytochrome P450 gene expression in human placenta in first trimester of pregnancy. Biochem Pharmacol 1996; 52: 379–83PubMedCrossRef Hakkola J, Raunio H, Purkunen R, et al. Detection of cytochrome P450 gene expression in human placenta in first trimester of pregnancy. Biochem Pharmacol 1996; 52: 379–83PubMedCrossRef
119.
Zurück zum Zitat Nelson DR, Kamataki T, Waxman DJ, et al. The P450 superfamily update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell Biol 1993; 12: 1–51PubMedCrossRef Nelson DR, Kamataki T, Waxman DJ, et al. The P450 superfamily update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell Biol 1993; 12: 1–51PubMedCrossRef
120.
Zurück zum Zitat Pasanen M, Helin-Martikainen RL, Pelkonen O, et al. Intrahepatic cholestasis of pregnancy impairs the activity of human placental xenobiotic and steroid metabolising enzymes in vitro. Placenta 1997; 18: 37–41PubMedCrossRef Pasanen M, Helin-Martikainen RL, Pelkonen O, et al. Intrahepatic cholestasis of pregnancy impairs the activity of human placental xenobiotic and steroid metabolising enzymes in vitro. Placenta 1997; 18: 37–41PubMedCrossRef
121.
Zurück zum Zitat Collier AC, Tingle MD, Paxton JW, et al. Metabolizing enzyme localisation and activities in the first trimester human placenta: the effect of maternal and gestational age, smoking and alcohol consumption. Hum Reprod 2002; 17: 2564–72PubMedCrossRef Collier AC, Tingle MD, Paxton JW, et al. Metabolizing enzyme localisation and activities in the first trimester human placenta: the effect of maternal and gestational age, smoking and alcohol consumption. Hum Reprod 2002; 17: 2564–72PubMedCrossRef
122.
Zurück zum Zitat Hakkola J, Pasanen M, Pelkonen O, et al. Expression of CYP1B1 in human adult and fetal tissues and differential inducibility of CYP1B1 and CYP1A1 by Ah-receptor ligands in human placenta and cultured cells. Carcinogenesis 1997; 18: 391–7PubMedCrossRef Hakkola J, Pasanen M, Pelkonen O, et al. Expression of CYP1B1 in human adult and fetal tissues and differential inducibility of CYP1B1 and CYP1A1 by Ah-receptor ligands in human placenta and cultured cells. Carcinogenesis 1997; 18: 391–7PubMedCrossRef
123.
Zurück zum Zitat Paakki P, Stockmann H, Rantola M, et al. Maternal drug abuse and human term placental xenobiotic and steroid metabolising enzymes in vitro. Environ Health Perspect 2000; 108: 141–5PubMedCrossRef Paakki P, Stockmann H, Rantola M, et al. Maternal drug abuse and human term placental xenobiotic and steroid metabolising enzymes in vitro. Environ Health Perspect 2000; 108: 141–5PubMedCrossRef
124.
Zurück zum Zitat Hincal F. Effects of exposure to air pollution and smoking on the placental aryl hydrocarbon hydroxylase (AHH) activity. Arch Environ Health 1986; 41: 377–83PubMedCrossRef Hincal F. Effects of exposure to air pollution and smoking on the placental aryl hydrocarbon hydroxylase (AHH) activity. Arch Environ Health 1986; 41: 377–83PubMedCrossRef
125.
Zurück zum Zitat Wong TK, Everson RB, Hsu ST. Potent induction of human placental monooxygenase activity by previous dietary exposure to polychlorinated biphenyls and their thermal degradation products. Lancet 1985; I: 721–4CrossRef Wong TK, Everson RB, Hsu ST. Potent induction of human placental monooxygenase activity by previous dietary exposure to polychlorinated biphenyls and their thermal degradation products. Lancet 1985; I: 721–4CrossRef
126.
Zurück zum Zitat Pasanen M, Taskinen T, Sotaniemi LA, et al. Inhibitor panel studies of human hepatic and placental cytochrome P-450-associated monooxygenase activities. Pharmacol Toxicol 1988; 62: 311–7PubMedCrossRef Pasanen M, Taskinen T, Sotaniemi LA, et al. Inhibitor panel studies of human hepatic and placental cytochrome P-450-associated monooxygenase activities. Pharmacol Toxicol 1988; 62: 311–7PubMedCrossRef
127.
Zurück zum Zitat Pasanen M, Pelkonen O. Xenobiotic and steroid-metabolising monooxygenases cataylsed by cytochrome P450 and glutathione S-transferase conjugations in the human placenta and theft relationships to maternal cigarette smoking. Placenta 1990; 11: 75–85PubMedCrossRef Pasanen M, Pelkonen O. Xenobiotic and steroid-metabolising monooxygenases cataylsed by cytochrome P450 and glutathione S-transferase conjugations in the human placenta and theft relationships to maternal cigarette smoking. Placenta 1990; 11: 75–85PubMedCrossRef
128.
Zurück zum Zitat McRobie DJ, Glover DD, Tracey TS. Effects of gestational and overt diabetes on human placental cytochromes P450 and glutathione S-transferase. Drug Metab Dispos 1998; 26: 367–71PubMed McRobie DJ, Glover DD, Tracey TS. Effects of gestational and overt diabetes on human placental cytochromes P450 and glutathione S-transferase. Drug Metab Dispos 1998; 26: 367–71PubMed
129.
Zurück zum Zitat Koskela S, Hakkola J, Hukkanen J, et al. Expression of CYP2A genes in human liver and extrahepatic tissues. Biochem Pharmacol 1999; 57: 1407–13PubMedCrossRef Koskela S, Hakkola J, Hukkanen J, et al. Expression of CYP2A genes in human liver and extrahepatic tissues. Biochem Pharmacol 1999; 57: 1407–13PubMedCrossRef
130.
Zurück zum Zitat Pienimäki P, Lampela E, Hakkola J, et al. Pharmacokinetics of oxcarbazepine and carbamazepine in human placenta. Epilepsia 1997; 38: 309–16PubMedCrossRef Pienimäki P, Lampela E, Hakkola J, et al. Pharmacokinetics of oxcarbazepine and carbamazepine in human placenta. Epilepsia 1997; 38: 309–16PubMedCrossRef
131.
Zurück zum Zitat Pasanen M, Haaparanta T, Sundin M, et al. Immunochemical and molecular biochemical studies on human placental cigarette smoke-inducible cytochrome P-450-dependent monooxygenase activities. Toxicology 1990; 62: 175–87PubMedCrossRef Pasanen M, Haaparanta T, Sundin M, et al. Immunochemical and molecular biochemical studies on human placental cigarette smoke-inducible cytochrome P-450-dependent monooxygenase activities. Toxicology 1990; 62: 175–87PubMedCrossRef
132.
Zurück zum Zitat Pelkonen O, Vähäkangas K, Kärki NT, et al. Genetic and environmental regulation of aryl hydrocarbon hydroxylase in man: studies with liver, lung, placenta, and lymphocytes. Toxicol Pathol 1984; 12: 256–60PubMedCrossRef Pelkonen O, Vähäkangas K, Kärki NT, et al. Genetic and environmental regulation of aryl hydrocarbon hydroxylase in man: studies with liver, lung, placenta, and lymphocytes. Toxicol Pathol 1984; 12: 256–60PubMedCrossRef
133.
Zurück zum Zitat Manchester DK, Gordon SK, Golas CL, et al. Ah receptor in human placenta: stabilization by molybdate and characterization of binding of 2,3,7,8-terachlorodibenzo-p-dioxin, 3-in-ethylcholanthrene, and benzo(a)pyrene. Cancer Res 1987; 36: 4861–8 Manchester DK, Gordon SK, Golas CL, et al. Ah receptor in human placenta: stabilization by molybdate and characterization of binding of 2,3,7,8-terachlorodibenzo-p-dioxin, 3-in-ethylcholanthrene, and benzo(a)pyrene. Cancer Res 1987; 36: 4861–8
134.
Zurück zum Zitat Pelkonen O, Jouppila P, Kärki NT, et al. Attempts to induce drug metabolism in human fetal liver and placenta by the administration of phenobarbital to mothers. Arch Int Pharmacodyn Ther 1973; 202: 288–97PubMed Pelkonen O, Jouppila P, Kärki NT, et al. Attempts to induce drug metabolism in human fetal liver and placenta by the administration of phenobarbital to mothers. Arch Int Pharmacodyn Ther 1973; 202: 288–97PubMed
135.
Zurück zum Zitat Pelkonen O, Arvela P, Kärki NT. 3,4-Benzo(a)pyrene and N-methylalanine metabolising enzymes in the immature human fetus and placenta. Acta Pharmacol Toxicol 1971; 30: 385–95CrossRef Pelkonen O, Arvela P, Kärki NT. 3,4-Benzo(a)pyrene and N-methylalanine metabolising enzymes in the immature human fetus and placenta. Acta Pharmacol Toxicol 1971; 30: 385–95CrossRef
136.
Zurück zum Zitat Pelkonen O, Jouppila P, Kärki NT. Effect of maternal cigarette smoking in 3,4-benzo(a)pyrene and N-methylalanine metabolism in human fetal liver and placenta. Toxicol Appl Pharmacol 1972; 23: 29–37CrossRef Pelkonen O, Jouppila P, Kärki NT. Effect of maternal cigarette smoking in 3,4-benzo(a)pyrene and N-methylalanine metabolism in human fetal liver and placenta. Toxicol Appl Pharmacol 1972; 23: 29–37CrossRef
137.
Zurück zum Zitat Gurtoo HL, Williams CI, Gottlieb K, et al. Population distribution of benzo(a)pyrene metabolism in smokers. Int J Cancer 1983; 31: 385–95CrossRef Gurtoo HL, Williams CI, Gottlieb K, et al. Population distribution of benzo(a)pyrene metabolism in smokers. Int J Cancer 1983; 31: 385–95CrossRef
138.
Zurück zum Zitat Shiverick KT, Salafia C. Cigarette smoking and pregnancy I: ovarian, uterine and placental effects. Placenta 1999; 20: 265–72PubMedCrossRef Shiverick KT, Salafia C. Cigarette smoking and pregnancy I: ovarian, uterine and placental effects. Placenta 1999; 20: 265–72PubMedCrossRef
139.
Zurück zum Zitat Rasheed A, Himes R, McCarver-May D. Variation in induction of human placental CYP2E1: possible role is susceptibility to fetal alcohol syndrome. Toxicol Appl Pharmacol 1997; 144: 396–400PubMedCrossRef Rasheed A, Himes R, McCarver-May D. Variation in induction of human placental CYP2E1: possible role is susceptibility to fetal alcohol syndrome. Toxicol Appl Pharmacol 1997; 144: 396–400PubMedCrossRef
140.
Zurück zum Zitat Karl P, Gordon B, Leiber C, et al. Acetaldehyde production and transfer in the perfused human placental cotyledon. Science 1988; 242: 273–5PubMedCrossRef Karl P, Gordon B, Leiber C, et al. Acetaldehyde production and transfer in the perfused human placental cotyledon. Science 1988; 242: 273–5PubMedCrossRef
141.
Zurück zum Zitat Vieira I, Pasanen M, Raunio H, et al. Expression of CYP2E1 in human lung and kidney during development and in full-term placenta: a differential methylation of the gene is involved in the regulation process. Pharmacol Toxicol 1998; 83: 183–7PubMedCrossRef Vieira I, Pasanen M, Raunio H, et al. Expression of CYP2E1 in human lung and kidney during development and in full-term placenta: a differential methylation of the gene is involved in the regulation process. Pharmacol Toxicol 1998; 83: 183–7PubMedCrossRef
142.
Zurück zum Zitat Nebert DW, Nelson DR, Coon MR, et al. The P450 superfamily: update on new sequences, gene mapping and recommended nomenclature. DNA Cell Biol 1991; 10: 1–14PubMedCrossRef Nebert DW, Nelson DR, Coon MR, et al. The P450 superfamily: update on new sequences, gene mapping and recommended nomenclature. DNA Cell Biol 1991; 10: 1–14PubMedCrossRef
143.
Zurück zum Zitat Mackenzie P, Owens I, Burchell B, et al. The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics 1997; 7: 255–69PubMedCrossRef Mackenzie P, Owens I, Burchell B, et al. The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics 1997; 7: 255–69PubMedCrossRef
144.
Zurück zum Zitat Collier AC, Tingle MD, Keelan JA, et al. A highly sensitive fluorescent microplate method for the determination of UDP-glucuronosyl transferase activity in tissues and placental cell lines. Drug Metab Dispos 2000; 28: 1184–6PubMed Collier AC, Tingle MD, Keelan JA, et al. A highly sensitive fluorescent microplate method for the determination of UDP-glucuronosyl transferase activity in tissues and placental cell lines. Drug Metab Dispos 2000; 28: 1184–6PubMed
145.
Zurück zum Zitat Ganley N. The expression and localisation of uridine diphosphate glucuronosyltransferase 2B subfamily in human placenta tissue [M.Sc. thesis]. Auckland: University of Auckland, 2001 Ganley N. The expression and localisation of uridine diphosphate glucuronosyltransferase 2B subfamily in human placenta tissue [M.Sc. thesis]. Auckland: University of Auckland, 2001
146.
Zurück zum Zitat Aitio A. UDP glucuronosyltransferase of the human placenta. Biochem Pharmacol 1974; 23: 2203–5PubMedCrossRef Aitio A. UDP glucuronosyltransferase of the human placenta. Biochem Pharmacol 1974; 23: 2203–5PubMedCrossRef
147.
Zurück zum Zitat Schenker S, Yang Y, Mattiuz E, et al. Olanzapine transfer by human placenta. Clin Exp Pharmacol Physiol 1999; 26: 691–7PubMedCrossRef Schenker S, Yang Y, Mattiuz E, et al. Olanzapine transfer by human placenta. Clin Exp Pharmacol Physiol 1999; 26: 691–7PubMedCrossRef
148.
Zurück zum Zitat Mannervick B, Widersten M. Human glutathione S-transferases: classification, tissue distribution, structure and functional properties. In: Pacific GM, Fracchia GN, editors. Advances in drug metabolism in man. Luxembourg: Office for Official Publications of the European Communities, 1995: 407–59 Mannervick B, Widersten M. Human glutathione S-transferases: classification, tissue distribution, structure and functional properties. In: Pacific GM, Fracchia GN, editors. Advances in drug metabolism in man. Luxembourg: Office for Official Publications of the European Communities, 1995: 407–59
149.
Zurück zum Zitat Nakasa N, Mera N, Ohmori S, et al. Nucleotide sequence of piclass glutathione S-transferase in human fetal liver. Res Commun Mol Pathol Pharmacol 1997; 97: 67–78PubMed Nakasa N, Mera N, Ohmori S, et al. Nucleotide sequence of piclass glutathione S-transferase in human fetal liver. Res Commun Mol Pathol Pharmacol 1997; 97: 67–78PubMed
150.
Zurück zum Zitat Guthenburg C, Mannervick B. Glutathione S-transferase (transferase pi) from human placenta is identical or closely related to glutathione S-transferase (transferase pi) from erythrocytes. Biochim Biophys Acta 1981; 661: 255–60CrossRef Guthenburg C, Mannervick B. Glutathione S-transferase (transferase pi) from human placenta is identical or closely related to glutathione S-transferase (transferase pi) from erythrocytes. Biochim Biophys Acta 1981; 661: 255–60CrossRef
151.
Zurück zum Zitat Finnell K, Buehler B, Kerr B, et al. Clinical and experimental studies linking oxidative metabolism to phenytoin-linked teratogenesis. Neurology 1992; 4: 25–31 Finnell K, Buehler B, Kerr B, et al. Clinical and experimental studies linking oxidative metabolism to phenytoin-linked teratogenesis. Neurology 1992; 4: 25–31
152.
Zurück zum Zitat Ratge D, Kohse KP, Steegmuller U, et al. Distribution of free and conjugated catecholamines between plasma, platelets and erythrocytes: different effects of intravenous and oral catecholamine administration. J Pharmacol Exp Ther 1991; 257: 232–8PubMed Ratge D, Kohse KP, Steegmuller U, et al. Distribution of free and conjugated catecholamines between plasma, platelets and erythrocytes: different effects of intravenous and oral catecholamine administration. J Pharmacol Exp Ther 1991; 257: 232–8PubMed
153.
Zurück zum Zitat Glatt H, Boeing H, Engelke CE. Human cytosolic sulphotransferases: genetics, characteristics, toxicological aspects. Mutat Res 2001; 482: 27–40PubMedCrossRef Glatt H, Boeing H, Engelke CE. Human cytosolic sulphotransferases: genetics, characteristics, toxicological aspects. Mutat Res 2001; 482: 27–40PubMedCrossRef
154.
Zurück zum Zitat Bernier F, Leblanc G, Labrie F, et al. The structure of human estrogen and aryl sulphotransferase gene: two mRNA species issued from a single gene. J Biol Chem 1994; 269: 28200–5PubMed Bernier F, Leblanc G, Labrie F, et al. The structure of human estrogen and aryl sulphotransferase gene: two mRNA species issued from a single gene. J Biol Chem 1994; 269: 28200–5PubMed
155.
Zurück zum Zitat Cappiello M, Giuliani L, Rane A, et al. Dopamine sulphotransferase is better developed than p-nitrophenol sulphotransferase in human fetus. Dev Pharmacol Ther 1991; 1991: 83–8 Cappiello M, Giuliani L, Rane A, et al. Dopamine sulphotransferase is better developed than p-nitrophenol sulphotransferase in human fetus. Dev Pharmacol Ther 1991; 1991: 83–8
156.
Zurück zum Zitat Sodha RJ, Glover V, Sandler M. Phenolsulphotransferase in human placenta. Biochem Pharmacol 1983; 32: 1655–7PubMedCrossRef Sodha RJ, Glover V, Sandler M. Phenolsulphotransferase in human placenta. Biochem Pharmacol 1983; 32: 1655–7PubMedCrossRef
157.
Zurück zum Zitat Sodha RJ, Schneider H. Sulphate conjugation of beta2-adrenoceptor stimulating drugs by platelet and placental phenol sulphotransferase. Br J Clin Pharmacol 1984; 17: 106–8PubMedCrossRef Sodha RJ, Schneider H. Sulphate conjugation of beta2-adrenoceptor stimulating drugs by platelet and placental phenol sulphotransferase. Br J Clin Pharmacol 1984; 17: 106–8PubMedCrossRef
158.
Zurück zum Zitat Cappiello M, Franchi M, Rane A, et al. Sulphotransferase and it substrate: adenosine-3′-phosphate-5′-phosphosulphate in human fetal liver and placenta. Dev Pharmacol Ther 1990; 14: 62–5PubMed Cappiello M, Franchi M, Rane A, et al. Sulphotransferase and it substrate: adenosine-3′-phosphate-5′-phosphosulphate in human fetal liver and placenta. Dev Pharmacol Ther 1990; 14: 62–5PubMed
159.
Zurück zum Zitat Weigand UW, Chou RC, Maulik D, et al. Assessment of biotransformation during transfer of propoxyphene and acetaminophen across the isolated perfused human placenta. Pediatr Pharmacol 1984; 4: 145–53 Weigand UW, Chou RC, Maulik D, et al. Assessment of biotransformation during transfer of propoxyphene and acetaminophen across the isolated perfused human placenta. Pediatr Pharmacol 1984; 4: 145–53
160.
Zurück zum Zitat Kennedy R, Miller R, Bell J, et al. Uptake and distribution of bupivicaine in fetal lambs. Anesthesiology 1986; 65: 247–53PubMedCrossRef Kennedy R, Miller R, Bell J, et al. Uptake and distribution of bupivicaine in fetal lambs. Anesthesiology 1986; 65: 247–53PubMedCrossRef
161.
Zurück zum Zitat Faber JJ, Thornburg KL. Placental physiology: structure and function of fetomaternal exchange. New York: Raven Press, 1983 Faber JJ, Thornburg KL. Placental physiology: structure and function of fetomaternal exchange. New York: Raven Press, 1983
162.
Zurück zum Zitat Hanshaw-Thomas A, Reynolds F. Placental transfer of bupivicaine, pethidine and lignocaine in the rabbit: effect of umbilical flow rate and protein content. Br J Obstet Gynaecol 1985; 92: 6–12 Hanshaw-Thomas A, Reynolds F. Placental transfer of bupivicaine, pethidine and lignocaine in the rabbit: effect of umbilical flow rate and protein content. Br J Obstet Gynaecol 1985; 92: 6–12
163.
Zurück zum Zitat Panigel M, Pascaud M, Brun JL. Une nouvelle technique de perfusion de l’espace intervilleux dans le placenta humain isole. Pathol Biol 1967; 15: 821 Panigel M, Pascaud M, Brun JL. Une nouvelle technique de perfusion de l’espace intervilleux dans le placenta humain isole. Pathol Biol 1967; 15: 821
164.
Zurück zum Zitat Brandes JM, Tavolini N, Potter BJ, et al. A new recycling technique for the human placental cotyledon perfusion: application to the studies of the fetomaternal transfer of glucose, insulin, and antipyrine. Am J Obstet Gynecol 1983; 146: 800–6PubMed Brandes JM, Tavolini N, Potter BJ, et al. A new recycling technique for the human placental cotyledon perfusion: application to the studies of the fetomaternal transfer of glucose, insulin, and antipyrine. Am J Obstet Gynecol 1983; 146: 800–6PubMed
165.
Zurück zum Zitat Schneider H, Panigel M, Dancis J. Transfer across the perfused human placenta of antipyrine, sodium, and leucine. Am J Obstet Gynecol 1972; 114: 822–8PubMed Schneider H, Panigel M, Dancis J. Transfer across the perfused human placenta of antipyrine, sodium, and leucine. Am J Obstet Gynecol 1972; 114: 822–8PubMed
166.
Zurück zum Zitat Schenker S, Dicke J, Johnson RF, et al. Human placental transport of cimetidine. J Clin Invest 1987; 80: 1428–34PubMedCrossRef Schenker S, Dicke J, Johnson RF, et al. Human placental transport of cimetidine. J Clin Invest 1987; 80: 1428–34PubMedCrossRef
167.
Zurück zum Zitat Holcberg G, Sapir O, Huleihel M, et al. Indomethacin activity in the fetal vasculature of normal and meconium exposed human placentae. Eur J Obstet Gynecol 2001; 94: 230–3CrossRef Holcberg G, Sapir O, Huleihel M, et al. Indomethacin activity in the fetal vasculature of normal and meconium exposed human placentae. Eur J Obstet Gynecol 2001; 94: 230–3CrossRef
168.
Zurück zum Zitat Sastry BVR, Hemontolor ME, Olenick M. Prostaglandin E2 in human placenta: its vascular effects and activation of prostaglandin E2 formation by nicotine and cotinine. Pharmacology 1999; 58: 70–86CrossRef Sastry BVR, Hemontolor ME, Olenick M. Prostaglandin E2 in human placenta: its vascular effects and activation of prostaglandin E2 formation by nicotine and cotinine. Pharmacology 1999; 58: 70–86CrossRef
169.
Zurück zum Zitat Frank HG, Morrish DW, Potgens A, et al. Cell culture models of human trophoblast: primary culture of trophoblast: a workshop report. Placenta 2001; 22 Suppl. A: 107–9CrossRef Frank HG, Morrish DW, Potgens A, et al. Cell culture models of human trophoblast: primary culture of trophoblast: a workshop report. Placenta 2001; 22 Suppl. A: 107–9CrossRef
170.
Zurück zum Zitat Hemmings DG, Lowen B, Sherburne R, et al. Villous trophoblasts cultured on semi-permeable membranes form an effective barrier to the passage of high and low molecular weight particles. Placenta 2001; 22: 70–9PubMedCrossRef Hemmings DG, Lowen B, Sherburne R, et al. Villous trophoblasts cultured on semi-permeable membranes form an effective barrier to the passage of high and low molecular weight particles. Placenta 2001; 22: 70–9PubMedCrossRef
171.
Zurück zum Zitat Liu F, Michael SJ, Kenneth AL. Permeability properties of monolayers of the trophoblast cell line BeWo. Am J Physiol 1997; 273: C1596–604PubMed Liu F, Michael SJ, Kenneth AL. Permeability properties of monolayers of the trophoblast cell line BeWo. Am J Physiol 1997; 273: C1596–604PubMed
172.
Zurück zum Zitat Ampasavate C, Chandorkar GA, Van der Velde DG, et al. Transport and metabolism of opioid peptides across BeWo cells, an in vitro model of the placental barrier. Int J Pharm 2002; 233: 85–98PubMedCrossRef Ampasavate C, Chandorkar GA, Van der Velde DG, et al. Transport and metabolism of opioid peptides across BeWo cells, an in vitro model of the placental barrier. Int J Pharm 2002; 233: 85–98PubMedCrossRef
173.
Zurück zum Zitat Bourget P, Fernandez H, Delouis C, et al. Pharmacokinetics of tobramycin in pregnant women: safety and efficacy of a oncedaily dose regimen. J Clin Pharm Ther 1991; 16: 167–76PubMedCrossRef Bourget P, Fernandez H, Delouis C, et al. Pharmacokinetics of tobramycin in pregnant women: safety and efficacy of a oncedaily dose regimen. J Clin Pharm Ther 1991; 16: 167–76PubMedCrossRef
174.
Zurück zum Zitat Schneider H. The role of the placenta in the nutrition of the human fetus. Am J Obstet Gynecol 1991; 164: 967–73PubMed Schneider H. The role of the placenta in the nutrition of the human fetus. Am J Obstet Gynecol 1991; 164: 967–73PubMed
175.
Zurück zum Zitat Boyd RDH, Haworth C, Stacey TE, et al. Permeability of the sheep placenta to unmetabolized polar nonelectrolytes. J Physiol 1976; 256: 617–34PubMed Boyd RDH, Haworth C, Stacey TE, et al. Permeability of the sheep placenta to unmetabolized polar nonelectrolytes. J Physiol 1976; 256: 617–34PubMed
176.
Zurück zum Zitat Thornburg KL, Faber JJ. Transfer of hydrophilic molecules by placenta and yolk-sac of the guinea pig. Am J Physiol 1977; 33: C111–24 Thornburg KL, Faber JJ. Transfer of hydrophilic molecules by placenta and yolk-sac of the guinea pig. Am J Physiol 1977; 33: C111–24
177.
Zurück zum Zitat King BF. Development and structure of the placenta and fetal membranes of nonhuman primates. J Exp Zool 1993; 266: 528–40PubMedCrossRef King BF. Development and structure of the placenta and fetal membranes of nonhuman primates. J Exp Zool 1993; 266: 528–40PubMedCrossRef
178.
Zurück zum Zitat Wolfgang MJ, Eisele SG, Browne MA, et al. Rhesus monkey placental transgene expression after lentiviral gene transfer into preimplantation embryos. Proc Natl Acad Sci USA 2001; 98: 10728–32PubMedCrossRef Wolfgang MJ, Eisele SG, Browne MA, et al. Rhesus monkey placental transgene expression after lentiviral gene transfer into preimplantation embryos. Proc Natl Acad Sci USA 2001; 98: 10728–32PubMedCrossRef
179.
Zurück zum Zitat Patterson TA, Binienda ZK, Newport GD, et al. Transplacental pharmacokinetics and fetal distribution of 2′, 3′-didehydro-3′-deoxythymidine (d4T) and its metabolites in late-term rhesus macaques. Teratology 2000; 62: 93–9PubMedCrossRef Patterson TA, Binienda ZK, Newport GD, et al. Transplacental pharmacokinetics and fetal distribution of 2′, 3′-didehydro-3′-deoxythymidine (d4T) and its metabolites in late-term rhesus macaques. Teratology 2000; 62: 93–9PubMedCrossRef
180.
Zurück zum Zitat Tuntland T, Odinecs A, Pereira CM, et al. In vitro models to predict the in vivo mechanism, rate and extent of placental transfer of dideoxynucleoside drugs against human immunodeficiency virus. Am J Obstet Gynecol 1999; 180: 198–206PubMedCrossRef Tuntland T, Odinecs A, Pereira CM, et al. In vitro models to predict the in vivo mechanism, rate and extent of placental transfer of dideoxynucleoside drugs against human immunodeficiency virus. Am J Obstet Gynecol 1999; 180: 198–206PubMedCrossRef
181.
Zurück zum Zitat Bonati M, Bortolus R, Marchetti F, et al. Drug use in pregnancy: an overview of epidemiological (drug use) studies. Eur J Clin Pharmacol 1990; 38: 325–8PubMedCrossRef Bonati M, Bortolus R, Marchetti F, et al. Drug use in pregnancy: an overview of epidemiological (drug use) studies. Eur J Clin Pharmacol 1990; 38: 325–8PubMedCrossRef
182.
Zurück zum Zitat Sabo A, Stanulovic M, Jakovljevic V, et al. Collaborative study on drug use in pregnancy: the results of the follow-up 10 years after (Novi Sad Centre). Pharmacoepidemiol Drug Saf 2001; 10: 229–35PubMedCrossRef Sabo A, Stanulovic M, Jakovljevic V, et al. Collaborative study on drug use in pregnancy: the results of the follow-up 10 years after (Novi Sad Centre). Pharmacoepidemiol Drug Saf 2001; 10: 229–35PubMedCrossRef
183.
Zurück zum Zitat Neiburg P, Marks JS, McLaren NM, et al. The fetal tobacco syndrome. JAMA 1985; 253: 2998–9CrossRef Neiburg P, Marks JS, McLaren NM, et al. The fetal tobacco syndrome. JAMA 1985; 253: 2998–9CrossRef
184.
Zurück zum Zitat Cnattingius S, Axelsson G, Eklund G, et al. Smoking, maternal age and fetal growth. Obstet Gynecol 1985; 66: 449–52PubMed Cnattingius S, Axelsson G, Eklund G, et al. Smoking, maternal age and fetal growth. Obstet Gynecol 1985; 66: 449–52PubMed
185.
Zurück zum Zitat Page KR, Bush P, Abramovich DR, et al. The effects of smoking on placental membranes. J Memb Sci 2002; 206: 243–52CrossRef Page KR, Bush P, Abramovich DR, et al. The effects of smoking on placental membranes. J Memb Sci 2002; 206: 243–52CrossRef
186.
Zurück zum Zitat Bush PG, Mayhew TM, Abramovich DR, et al. A quantitative study on the effects of maternal smoking on placental morphology and cadmium concentration. Placenta 2000; 21: 247–56PubMedCrossRef Bush PG, Mayhew TM, Abramovich DR, et al. A quantitative study on the effects of maternal smoking on placental morphology and cadmium concentration. Placenta 2000; 21: 247–56PubMedCrossRef
187.
Zurück zum Zitat Shepard TH. Catalog of teratogenic agents. Baltimore: John Hopkins University Press, 2001 Shepard TH. Catalog of teratogenic agents. Baltimore: John Hopkins University Press, 2001
188.
Zurück zum Zitat Lehtovirta P, Fross M, Rauramo I, et al. Acute effects of nicotine on fetal heart rate variability. Br J Obstet Gynaecol 1983; 90: 710–5PubMedCrossRef Lehtovirta P, Fross M, Rauramo I, et al. Acute effects of nicotine on fetal heart rate variability. Br J Obstet Gynaecol 1983; 90: 710–5PubMedCrossRef
189.
Zurück zum Zitat Manning FA, Feyerabend C. Cigarette smoking and fetal breathing movements. Br J Obstet Gynaecol 1976; 83: 262–70PubMedCrossRef Manning FA, Feyerabend C. Cigarette smoking and fetal breathing movements. Br J Obstet Gynaecol 1976; 83: 262–70PubMedCrossRef
190.
Zurück zum Zitat Pastrakuljic A, Schwartz R, Simone C, et al. Transplacental transfer and biotransformation studies of nicotine in the human placental cotyledon perfused in vitro. Life Sci 1998; 63: 2333–42PubMedCrossRef Pastrakuljic A, Schwartz R, Simone C, et al. Transplacental transfer and biotransformation studies of nicotine in the human placental cotyledon perfused in vitro. Life Sci 1998; 63: 2333–42PubMedCrossRef
191.
Zurück zum Zitat Sastry BVR, Chance MB. Biotransformation of nicotine in the perfused human placenta [abstract]. Placenta 1994; 15: A56 Sastry BVR, Chance MB. Biotransformation of nicotine in the perfused human placenta [abstract]. Placenta 1994; 15: A56
192.
Zurück zum Zitat Kerenyi TD, Gleicher N, Meller J, et al. Transplacental cardioversion of intrauterine superventricular tachycardia with digitalis. Lancet 1980; II: 393–4CrossRef Kerenyi TD, Gleicher N, Meller J, et al. Transplacental cardioversion of intrauterine superventricular tachycardia with digitalis. Lancet 1980; II: 393–4CrossRef
193.
Zurück zum Zitat Kleinman CS, Copel JA. Fetal cardiac arrhythmias: diagnosis and therapy. In: Creasy RK, Resnick R, editors. Maternal-fetal medicine: principles and practice. Philadelphia: WB Saunders, 1994: 326–41 Kleinman CS, Copel JA. Fetal cardiac arrhythmias: diagnosis and therapy. In: Creasy RK, Resnick R, editors. Maternal-fetal medicine: principles and practice. Philadelphia: WB Saunders, 1994: 326–41
194.
Zurück zum Zitat Southall DP, Richards J, Hardwick R-A, et al. Prospective study of fetal heart rate and rhythm patterns. Arch Dis Child 1980; 55: 506–11PubMedCrossRef Southall DP, Richards J, Hardwick R-A, et al. Prospective study of fetal heart rate and rhythm patterns. Arch Dis Child 1980; 55: 506–11PubMedCrossRef
195.
Zurück zum Zitat Meijboom EJ, van Engelen AD, van de Beck EW, et al. Fetal arrhythmias. Curr Opin Cardiol 1994; 9: 97–102PubMedCrossRef Meijboom EJ, van Engelen AD, van de Beck EW, et al. Fetal arrhythmias. Curr Opin Cardiol 1994; 9: 97–102PubMedCrossRef
196.
Zurück zum Zitat Ito S. Transplacental treatment of fetal tachycardia: implications of drug transporting proteins in placenta. Semin Perinatol 2001; 25: 196–201PubMedCrossRef Ito S. Transplacental treatment of fetal tachycardia: implications of drug transporting proteins in placenta. Semin Perinatol 2001; 25: 196–201PubMedCrossRef
197.
Zurück zum Zitat Azancot-Benisty A, Jacqz-Aigrain E, Guirgis NM, et al. Clinical and pharmacologic study of fetal supraventricular tachyarrhythmias. J Pediatr 1992; 121: 608–13PubMedCrossRef Azancot-Benisty A, Jacqz-Aigrain E, Guirgis NM, et al. Clinical and pharmacologic study of fetal supraventricular tachyarrhythmias. J Pediatr 1992; 121: 608–13PubMedCrossRef
198.
Zurück zum Zitat Younis JS, Granat M. Insufficient transplacental digoxin transfer in severe fetal hydrops fetalis. Am J Obstet Gynecol 1987; 157: 1268–9PubMed Younis JS, Granat M. Insufficient transplacental digoxin transfer in severe fetal hydrops fetalis. Am J Obstet Gynecol 1987; 157: 1268–9PubMed
199.
Zurück zum Zitat Weiner CP, Thompson MIB. Direct treatment of fetal supraventricular tachycardia after failed transplacental therapy. Am J Obstet Gynecol 1988; 158: 570–3PubMed Weiner CP, Thompson MIB. Direct treatment of fetal supraventricular tachycardia after failed transplacental therapy. Am J Obstet Gynecol 1988; 158: 570–3PubMed
200.
Zurück zum Zitat Arnoux P, Seyral P, Llurens M, et al. Amiodarone and digoxin for refractory fetal tachycardia. Am J Cardiol 1987; 59: 166–7PubMedCrossRef Arnoux P, Seyral P, Llurens M, et al. Amiodarone and digoxin for refractory fetal tachycardia. Am J Cardiol 1987; 59: 166–7PubMedCrossRef
201.
Zurück zum Zitat Spinnato JA, Shaver DC, Flinn GS, et al. Fetal supraventricular tachycardia: in utero therapy with digoxin and quinidine. Obstet Gynecol 1984; 64: 730–5PubMed Spinnato JA, Shaver DC, Flinn GS, et al. Fetal supraventricular tachycardia: in utero therapy with digoxin and quinidine. Obstet Gynecol 1984; 64: 730–5PubMed
202.
Zurück zum Zitat Parilla BV, Grobman WA, Holtzman RB, et al. Indomethacin tocolysis and risk of necrotizing enterocolitis. Obstet Gynecol 2000; 96: 120–3PubMedCrossRef Parilla BV, Grobman WA, Holtzman RB, et al. Indomethacin tocolysis and risk of necrotizing enterocolitis. Obstet Gynecol 2000; 96: 120–3PubMedCrossRef
203.
Zurück zum Zitat Abramov Y, Nadjari M, Weinstein D, et al. Indomethacin for preterm labor: a randomized comparison of vaginal and rectaloral routes. Obstet Gynecol 2000; 95: 482–6PubMedCrossRef Abramov Y, Nadjari M, Weinstein D, et al. Indomethacin for preterm labor: a randomized comparison of vaginal and rectaloral routes. Obstet Gynecol 2000; 95: 482–6PubMedCrossRef
204.
Zurück zum Zitat Nielsen GL, Sorensen HT, Larsen H, et al. Risk of adverse birth outcome and miscarriage in pregnant users of non-steroidal anti-inflammatory drugs: population based observational study and case-control study. BMJ 2001; 322: 266–70PubMedCrossRef Nielsen GL, Sorensen HT, Larsen H, et al. Risk of adverse birth outcome and miscarriage in pregnant users of non-steroidal anti-inflammatory drugs: population based observational study and case-control study. BMJ 2001; 322: 266–70PubMedCrossRef
205.
Zurück zum Zitat Ericson A, Kallen BA. Nonsteroidal anti-inflammatory drugs in early pregnancy. Reprod Toxicol 2001; 15: 371–5PubMedCrossRef Ericson A, Kallen BA. Nonsteroidal anti-inflammatory drugs in early pregnancy. Reprod Toxicol 2001; 15: 371–5PubMedCrossRef
206.
Zurück zum Zitat Schoenfeld A, Bar Y, Merlob P, et al. NSAIDs: maternal and fetal considerations. Am J Reprod Immunol 1992; 28: 141–7PubMed Schoenfeld A, Bar Y, Merlob P, et al. NSAIDs: maternal and fetal considerations. Am J Reprod Immunol 1992; 28: 141–7PubMed
207.
Zurück zum Zitat McGarrity C, Samani N, Beck F, et al. The effect of sodium salicylate on the rat embryo in culture: an in vitro model for the morphological assessment of teratogenicity. J Anat 1981; 133: 257–69PubMed McGarrity C, Samani N, Beck F, et al. The effect of sodium salicylate on the rat embryo in culture: an in vitro model for the morphological assessment of teratogenicity. J Anat 1981; 133: 257–69PubMed
208.
Zurück zum Zitat Chan LY, Chiu PY, Siu SS, et al. A study of diclofenac-induced teratogenicity during organogenesis using a whole rat embryo culture model. Hum Reprod 2001; 16: 2390–3PubMed Chan LY, Chiu PY, Siu SS, et al. A study of diclofenac-induced teratogenicity during organogenesis using a whole rat embryo culture model. Hum Reprod 2001; 16: 2390–3PubMed
209.
Zurück zum Zitat Foulon O, Jaussely C, Repetto M, et al. Postnatal evolution of supernumerary ribs in rats after a single administration of sodium salicylate. J Appl Toxicol 2000; 20: 205–9PubMedCrossRef Foulon O, Jaussely C, Repetto M, et al. Postnatal evolution of supernumerary ribs in rats after a single administration of sodium salicylate. J Appl Toxicol 2000; 20: 205–9PubMedCrossRef
210.
Zurück zum Zitat Nelson JL, Ostensen M. Pregnancy and rheumatoid arthritis. Rheum Dis Clin North Am 1997; 23: 195–212PubMedCrossRef Nelson JL, Ostensen M. Pregnancy and rheumatoid arthritis. Rheum Dis Clin North Am 1997; 23: 195–212PubMedCrossRef
211.
Zurück zum Zitat Akbaraly R, Leng JJ, Brachet-Liermain A, et al. Trans-placental transfer of four anti-inflammatory agents: a study carried out by in vitro perfusion. J Gynecol Obstet Biol Reprod (Paris) 1981; 10: 7–11 Akbaraly R, Leng JJ, Brachet-Liermain A, et al. Trans-placental transfer of four anti-inflammatory agents: a study carried out by in vitro perfusion. J Gynecol Obstet Biol Reprod (Paris) 1981; 10: 7–11
212.
Zurück zum Zitat Lampela ES, Nuutinen LH, Ala-Kokko TI, et al. Placental transfer of sulindac, sulindac sulfide, and indomethacin in a human placental perfusion model. Am J Obstet Gynecol 1999; 180: 174–80PubMedCrossRef Lampela ES, Nuutinen LH, Ala-Kokko TI, et al. Placental transfer of sulindac, sulindac sulfide, and indomethacin in a human placental perfusion model. Am J Obstet Gynecol 1999; 180: 174–80PubMedCrossRef
213.
Zurück zum Zitat Siu SSN, Yeung JHK, Lau TK. A study on placental transfer of diclofenac in first trimester of human pregnancy. Hum Reprod 2000; 15: 2423–5PubMedCrossRef Siu SSN, Yeung JHK, Lau TK. A study on placental transfer of diclofenac in first trimester of human pregnancy. Hum Reprod 2000; 15: 2423–5PubMedCrossRef
214.
Zurück zum Zitat Slattery MM, Friel AM, Healy DG, et al. Uterine relaxant effects of cyclooxygenase-2 inhibitors in vitro. Obstet Gynecol 2001; 98: 563–9PubMedCrossRef Slattery MM, Friel AM, Healy DG, et al. Uterine relaxant effects of cyclooxygenase-2 inhibitors in vitro. Obstet Gynecol 2001; 98: 563–9PubMedCrossRef
215.
Zurück zum Zitat Sakai M, Tanebe K, Sasaki Y, et al. Evaluation of the tocolytic effect of a selective cyclooxygenase-2 inhibitor in a mouse model of lipopolysaccharide-induced preterm delivery. Mol Hum Reprod 2001; 7: 595–602PubMedCrossRef Sakai M, Tanebe K, Sasaki Y, et al. Evaluation of the tocolytic effect of a selective cyclooxygenase-2 inhibitor in a mouse model of lipopolysaccharide-induced preterm delivery. Mol Hum Reprod 2001; 7: 595–602PubMedCrossRef
216.
Zurück zum Zitat Gross G, Imamura T, Vogt SK, et al. Inhibition of cyclooxyganase-2 prevents inflammation-mediated preterm labor in the mouse. Am J Physiol Regul Integr Comp Physiol 2000; 278: R1415–23PubMed Gross G, Imamura T, Vogt SK, et al. Inhibition of cyclooxyganase-2 prevents inflammation-mediated preterm labor in the mouse. Am J Physiol Regul Integr Comp Physiol 2000; 278: R1415–23PubMed
217.
Zurück zum Zitat Takahashi Y, Roman C, Chemtob S, et al. Cyclooxygenase-2 inhibitors constrict the fetal lamb ductus arteriosus both in vitro and in vivo. Am J Physiol Regul Integr Comp Physiol 2000; 278: R1496–505PubMed Takahashi Y, Roman C, Chemtob S, et al. Cyclooxygenase-2 inhibitors constrict the fetal lamb ductus arteriosus both in vitro and in vivo. Am J Physiol Regul Integr Comp Physiol 2000; 278: R1496–505PubMed
218.
Zurück zum Zitat Sawdy R, Slater D, Fisk N, et al. Use of cyclo-oxygenase type-2-selective non-steroidal anti-inflammatory agent to prevent preterm delivery. Lancet 1997; 350: 265–6PubMedCrossRef Sawdy R, Slater D, Fisk N, et al. Use of cyclo-oxygenase type-2-selective non-steroidal anti-inflammatory agent to prevent preterm delivery. Lancet 1997; 350: 265–6PubMedCrossRef
219.
Zurück zum Zitat Khan KN, Stanfield KM, Dannenberg A, et al. Cyclooxygenase-2 expression in the developing human kidney. Pediatr Dev Pathol 2001; 4: 461–6PubMedCrossRef Khan KN, Stanfield KM, Dannenberg A, et al. Cyclooxygenase-2 expression in the developing human kidney. Pediatr Dev Pathol 2001; 4: 461–6PubMedCrossRef
220.
Zurück zum Zitat Lassus P, Wolff H, Andersson S. Cyclooxygenase-2 in human perinatal lung. Pediatr Res 2000; 47: 602–5PubMedCrossRef Lassus P, Wolff H, Andersson S. Cyclooxygenase-2 in human perinatal lung. Pediatr Res 2000; 47: 602–5PubMedCrossRef
221.
Zurück zum Zitat Maslinska D, Kaliszek A, Opertowska J, et al. Constitutive expression of cyclooxygenase-2 (COX-2) in developing brain: a. choroid plexus in human fetuses. Folia Neuropathol 1999; 37: 287–91PubMed Maslinska D, Kaliszek A, Opertowska J, et al. Constitutive expression of cyclooxygenase-2 (COX-2) in developing brain: a. choroid plexus in human fetuses. Folia Neuropathol 1999; 37: 287–91PubMed
222.
Zurück zum Zitat Newell ML. Mechanism and timing of mother-to-child transmission of HIV-1. AIDS 1998; 12: 831–7PubMedCrossRef Newell ML. Mechanism and timing of mother-to-child transmission of HIV-1. AIDS 1998; 12: 831–7PubMedCrossRef
223.
Zurück zum Zitat Mofenson LM, Lambert JS, Stiehm ER, et al. Pediatric AIDS Clinical Trials Group Study 185 Team. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. N Engl J Med 1999; 341: 385–93PubMedCrossRef Mofenson LM, Lambert JS, Stiehm ER, et al. Pediatric AIDS Clinical Trials Group Study 185 Team. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. N Engl J Med 1999; 341: 385–93PubMedCrossRef
224.
Zurück zum Zitat Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994; 331: 1173–80PubMedCrossRef Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994; 331: 1173–80PubMedCrossRef
225.
Zurück zum Zitat Madelbrot L, Peyavin G, Firtion G, et al. Maternal-fetal transfer and amniotic fluid accumulation of lamivudine in human immunodeficiency virus-infected pregnant women. Am J Obstet Gynecol 2001; 184: 153–8CrossRef Madelbrot L, Peyavin G, Firtion G, et al. Maternal-fetal transfer and amniotic fluid accumulation of lamivudine in human immunodeficiency virus-infected pregnant women. Am J Obstet Gynecol 2001; 184: 153–8CrossRef
226.
Zurück zum Zitat Casey BM, Bawdon RE. Placental transfer of ritonavir with zidovudine in the ex vivo placental perfusion model. Am J Obstet Gynecol 1998; 179: 758–61PubMedCrossRef Casey BM, Bawdon RE. Placental transfer of ritonavir with zidovudine in the ex vivo placental perfusion model. Am J Obstet Gynecol 1998; 179: 758–61PubMedCrossRef
227.
Zurück zum Zitat Forestier F, de Renty P, Peytavin G, et al. Maternal-fetal transfer of saquinavir studied in the ex vivo placental perfusion model. Am J Obstet Gynecol 2001; 185: 178–81PubMedCrossRef Forestier F, de Renty P, Peytavin G, et al. Maternal-fetal transfer of saquinavir studied in the ex vivo placental perfusion model. Am J Obstet Gynecol 2001; 185: 178–81PubMedCrossRef
228.
Zurück zum Zitat Marzolini C, Rudin C, Decosterd LA, et al. Transplacental passage of protease inhibitors at delivery. AIDS 2002; 16: 889–93PubMedCrossRef Marzolini C, Rudin C, Decosterd LA, et al. Transplacental passage of protease inhibitors at delivery. AIDS 2002; 16: 889–93PubMedCrossRef
229.
Zurück zum Zitat Minkoff H, Augenbraun M. Antiretroviral therapy for pregnant women. Am J Obstet Gynecol 1997; 176: 478–89PubMedCrossRef Minkoff H, Augenbraun M. Antiretroviral therapy for pregnant women. Am J Obstet Gynecol 1997; 176: 478–89PubMedCrossRef
230.
Zurück zum Zitat Pascual MJ, Macias RIR, Garcia-Del-Pozo J, et al. Enhanced efficiency of the placental barrier to cisplatin through binding to glycocholic acid. Anticancer Res 2001; 21: 2703–8PubMed Pascual MJ, Macias RIR, Garcia-Del-Pozo J, et al. Enhanced efficiency of the placental barrier to cisplatin through binding to glycocholic acid. Anticancer Res 2001; 21: 2703–8PubMed
231.
Zurück zum Zitat Marin JJG, Bravo P, El-Mir MYA, et al. ATP-dependent bile acid transport across the microvillous membrane of human term trophoblast. Am J Physiol 1995; 268: G685–94PubMed Marin JJG, Bravo P, El-Mir MYA, et al. ATP-dependent bile acid transport across the microvillous membrane of human term trophoblast. Am J Physiol 1995; 268: G685–94PubMed
232.
Zurück zum Zitat Liggins GC. Premature delivery of foetal lambs infused with glucocorticoids. J Endocrinol 1969; 45: 515–23PubMedCrossRef Liggins GC. Premature delivery of foetal lambs infused with glucocorticoids. J Endocrinol 1969; 45: 515–23PubMedCrossRef
233.
Zurück zum Zitat Spinillo A, Capuzzo E, Ometto A, et al. Value of antenatal corticosteroid therapy in preterm birth. Early Hum Dev 1995; 42: 37–47PubMedCrossRef Spinillo A, Capuzzo E, Ometto A, et al. Value of antenatal corticosteroid therapy in preterm birth. Early Hum Dev 1995; 42: 37–47PubMedCrossRef
234.
Zurück zum Zitat Ward RM. Pharmacologic enhancement of fetal lung maturation. Clin Perinatal 1994; 21: 523–42 Ward RM. Pharmacologic enhancement of fetal lung maturation. Clin Perinatal 1994; 21: 523–42
235.
Zurück zum Zitat Ballard PL, Ballard RA. Scientific basis and theapeutic regimens for use of antenatal glucocorticoids. Am J Obstet Gynecol 1995; 173: 254–62PubMedCrossRef Ballard PL, Ballard RA. Scientific basis and theapeutic regimens for use of antenatal glucocorticoids. Am J Obstet Gynecol 1995; 173: 254–62PubMedCrossRef
236.
Zurück zum Zitat Crowley P, Chalmers I, Keirse MJNC. The effects of corticosteroid administration before preterm delivery: an overview of the evidence from controlled trials. Br J Obstet Gynaecol 1990; 97: 11–25PubMedCrossRef Crowley P, Chalmers I, Keirse MJNC. The effects of corticosteroid administration before preterm delivery: an overview of the evidence from controlled trials. Br J Obstet Gynaecol 1990; 97: 11–25PubMedCrossRef
237.
Zurück zum Zitat Natlonal Institutes of Health. Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH Consens Statement 1994 Feb 28–Mar 2; 12(2): 1–24 Natlonal Institutes of Health. Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH Consens Statement 1994 Feb 28–Mar 2; 12(2): 1–24
238.
Zurück zum Zitat Wright LL, Verter J, Younes N, et al. Antenatal corticosteroid administration and neonatal outcome in very low birthweight infants: The NICHD Neonatal Research Network. Am J Obstet Gynecol 1995; 173: 269–74PubMedCrossRef Wright LL, Verter J, Younes N, et al. Antenatal corticosteroid administration and neonatal outcome in very low birthweight infants: The NICHD Neonatal Research Network. Am J Obstet Gynecol 1995; 173: 269–74PubMedCrossRef
239.
Zurück zum Zitat Horbar JD. Antenatal corticosteroid treatment and neonatal outcomes for infants 501 to 1500gm in the Vermont-Oxford Trials Network. Am J Obstet Gynecol 1995; 173: 275–81PubMedCrossRef Horbar JD. Antenatal corticosteroid treatment and neonatal outcomes for infants 501 to 1500gm in the Vermont-Oxford Trials Network. Am J Obstet Gynecol 1995; 173: 275–81PubMedCrossRef
240.
Zurück zum Zitat Anderson DF, Stock MK, Rankin JHG. Placental transfer of dexamethasone in near-term sheep. J Dev Physiol 1979; 1: 431–6PubMed Anderson DF, Stock MK, Rankin JHG. Placental transfer of dexamethasone in near-term sheep. J Dev Physiol 1979; 1: 431–6PubMed
241.
Zurück zum Zitat Varma DR. Investigation of the maternal to fetal serum concentration gradient of dexamethasone in the rat. Br J Pharmacol 1986; 88: 815–20PubMedCrossRef Varma DR. Investigation of the maternal to fetal serum concentration gradient of dexamethasone in the rat. Br J Pharmacol 1986; 88: 815–20PubMedCrossRef
242.
Zurück zum Zitat Smith MA, Thomford PJ, Mattison DR, et al. Transport and metabolism of dexamethasone in the dually perfused human placenta. Reprod Toxicol 1988; 2: 37–43PubMedCrossRef Smith MA, Thomford PJ, Mattison DR, et al. Transport and metabolism of dexamethasone in the dually perfused human placenta. Reprod Toxicol 1988; 2: 37–43PubMedCrossRef
243.
Zurück zum Zitat Levitz M, Jansen V, Dancis J. The transfer and metabolism of corticosteroids in the perfused human placenta. Am J Obstet Gynecol 1978; 132: 363–6PubMed Levitz M, Jansen V, Dancis J. The transfer and metabolism of corticosteroids in the perfused human placenta. Am J Obstet Gynecol 1978; 132: 363–6PubMed
244.
245.
Zurück zum Zitat Maillefert JF, Duchamp O, Solary E, et al. Effects of cyclosporin at various concentrations on dexamethasone intracellular uptake in multidrug resistant cells. Ann Rheum Dis 2000; 59: 146–8PubMedCrossRef Maillefert JF, Duchamp O, Solary E, et al. Effects of cyclosporin at various concentrations on dexamethasone intracellular uptake in multidrug resistant cells. Ann Rheum Dis 2000; 59: 146–8PubMedCrossRef
246.
Zurück zum Zitat Meijer OC, de Lange EC, Breimer DD, et al. Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1A P-glycoprotein knockout mice. Endocrinology 1998; 139: 1789–93PubMedCrossRef Meijer OC, de Lange EC, Breimer DD, et al. Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1A P-glycoprotein knockout mice. Endocrinology 1998; 139: 1789–93PubMedCrossRef
247.
Zurück zum Zitat Coutelle C, Douar AM, Colledge W, et al. The challenge of fetal gene therapy. Nat Med 1995; 1: 864–6PubMedCrossRef Coutelle C, Douar AM, Colledge W, et al. The challenge of fetal gene therapy. Nat Med 1995; 1: 864–6PubMedCrossRef
248.
Zurück zum Zitat Sawai K, Meruelo D. Cell specific transfection of choriocarcinoma cells by using Sindbis virus hCG expressing chimeric vector. Biochem Biophys Res Commun 1998; 248: 315–23PubMedCrossRef Sawai K, Meruelo D. Cell specific transfection of choriocarcinoma cells by using Sindbis virus hCG expressing chimeric vector. Biochem Biophys Res Commun 1998; 248: 315–23PubMedCrossRef
249.
Zurück zum Zitat Heikkila A, Myllynen P, Keski-Nisula L, et al. Gene transfer to human placenta ex vivo: a novel application of dual perfusion of human placental cotyledon. Am J Obstet Gynecol 2002; 186: 1046–51PubMedCrossRef Heikkila A, Myllynen P, Keski-Nisula L, et al. Gene transfer to human placenta ex vivo: a novel application of dual perfusion of human placental cotyledon. Am J Obstet Gynecol 2002; 186: 1046–51PubMedCrossRef
250.
Zurück zum Zitat Rosen TS, Pippenger CE. Disposition of methadone and its relationship to severity of withdrawal in the newborn. Addict Dis 1975; 2: 169–78PubMed Rosen TS, Pippenger CE. Disposition of methadone and its relationship to severity of withdrawal in the newborn. Addict Dis 1975; 2: 169–78PubMed
251.
Zurück zum Zitat Fisher G, Gombas W, Eder H, et al. Buprenorphine versus methadone maintenance for the treatment of opioid dependence. Addiction 1999; 94: 1337–47CrossRef Fisher G, Gombas W, Eder H, et al. Buprenorphine versus methadone maintenance for the treatment of opioid dependence. Addiction 1999; 94: 1337–47CrossRef
252.
Zurück zum Zitat Johnson RE, Jaffe JH, Fudala PJ. A controlled trial of buprenorphine treatment for opioid dependence. JAMA 1992; 267: 2750–5PubMedCrossRef Johnson RE, Jaffe JH, Fudala PJ. A controlled trial of buprenorphine treatment for opioid dependence. JAMA 1992; 267: 2750–5PubMedCrossRef
253.
Zurück zum Zitat Ling W, Charuvastra C, Collins J. Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial. Addiction 1998; 93: 475–586PubMedCrossRef Ling W, Charuvastra C, Collins J. Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial. Addiction 1998; 93: 475–586PubMedCrossRef
254.
Zurück zum Zitat Fisher G, Rolley JE, Eder H, et al. Treatment of opioiddependent pregnant women with buprenorphine. Addiction 2000; 95: 239–44CrossRef Fisher G, Rolley JE, Eder H, et al. Treatment of opioiddependent pregnant women with buprenorphine. Addiction 2000; 95: 239–44CrossRef
255.
Zurück zum Zitat Marquet P, Chevrel J, Lavignasse P, et al. Buprenorphine withdrawal in a newborn. Clin Pharmacol Ther 1997; 62: 569–71PubMedCrossRef Marquet P, Chevrel J, Lavignasse P, et al. Buprenorphine withdrawal in a newborn. Clin Pharmacol Ther 1997; 62: 569–71PubMedCrossRef
256.
Zurück zum Zitat Ganapathy V, Prasad PD, Ganapathy ME, et al. Drags of abuse and placental transport. Adv Drag Deliv Rev 1999; 1: 99–110CrossRef Ganapathy V, Prasad PD, Ganapathy ME, et al. Drags of abuse and placental transport. Adv Drag Deliv Rev 1999; 1: 99–110CrossRef
257.
Zurück zum Zitat Ganapathy V, Ramamoorthy S, Leibach FH. Transport and metabolism of monoamines in the human placenta. Trophoblast Res 1993; 7: 35–51 Ganapathy V, Ramamoorthy S, Leibach FH. Transport and metabolism of monoamines in the human placenta. Trophoblast Res 1993; 7: 35–51
258.
Zurück zum Zitat Ganapathy V, Leibach FH. Placental biogenic amines and their transporters. In: Sastry BVR, editor. Placental toxicology. Boca Raton: CRC Press, 1995: 161–74 Ganapathy V, Leibach FH. Placental biogenic amines and their transporters. In: Sastry BVR, editor. Placental toxicology. Boca Raton: CRC Press, 1995: 161–74
259.
Zurück zum Zitat Fergusson DM, Horwood LJ, Northstone K, et al. Maternal use of cannabis and pregnancy outcome. BJOG 2002; 109: 21–7PubMedCrossRef Fergusson DM, Horwood LJ, Northstone K, et al. Maternal use of cannabis and pregnancy outcome. BJOG 2002; 109: 21–7PubMedCrossRef
260.
Zurück zum Zitat Harbison RD, Mantilla-Plata B. Prenatal toxicity, maternal distribution and placental transfer of tetrahydrocannabinol. J Pharmacol Exp Ther 1972; 180: 446–53PubMed Harbison RD, Mantilla-Plata B. Prenatal toxicity, maternal distribution and placental transfer of tetrahydrocannabinol. J Pharmacol Exp Ther 1972; 180: 446–53PubMed
261.
Zurück zum Zitat Fried PA, Smith AM. A literature review of the consequences of prenatal marihuana exposure: an emerging theme of a deficiency in aspects of executive function. Neurotoxicol Teratol 2001; 23: 1–11PubMedCrossRef Fried PA, Smith AM. A literature review of the consequences of prenatal marihuana exposure: an emerging theme of a deficiency in aspects of executive function. Neurotoxicol Teratol 2001; 23: 1–11PubMedCrossRef
262.
Zurück zum Zitat Goldschmidt L, Day NL, Richardson GA. Effects of prenatal marijuana exposure on child behaviour problems at age 10. Neurotoxicol Teratol 2000; 22: 325–36PubMedCrossRef Goldschmidt L, Day NL, Richardson GA. Effects of prenatal marijuana exposure on child behaviour problems at age 10. Neurotoxicol Teratol 2000; 22: 325–36PubMedCrossRef
263.
Zurück zum Zitat Bailey JR, Cunny HC, Paule M, et al. Fetal disposition of delta 9-tetrahydrocannabinol (THC) during late pregnancy in the rhesus monkey. Toxicol Appl Pharmacol 1987; 90: 315–21PubMedCrossRef Bailey JR, Cunny HC, Paule M, et al. Fetal disposition of delta 9-tetrahydrocannabinol (THC) during late pregnancy in the rhesus monkey. Toxicol Appl Pharmacol 1987; 90: 315–21PubMedCrossRef
264.
Zurück zum Zitat Abrams RM, Cook CE, Davis KH, et al. Plasma delta-9-tetrahydrocannabinol in pregnant sheep and fetus after inhalation of smoke from a marijuana cigarette. Alcohol Drag Res 1985/1986; 6: 361–9 Abrams RM, Cook CE, Davis KH, et al. Plasma delta-9-tetrahydrocannabinol in pregnant sheep and fetus after inhalation of smoke from a marijuana cigarette. Alcohol Drag Res 1985/1986; 6: 361–9
265.
Zurück zum Zitat Blackard C, Tennes K. Human placental transfer of cannabinoids [letter]. N Engl J Med 1984; 20: 797 Blackard C, Tennes K. Human placental transfer of cannabinoids [letter]. N Engl J Med 1984; 20: 797
Metadaten
Titel
Drug Transfer and Metabolism by the Human Placenta
verfasst von
Michael R. Syme
James W. Paxton
Dr Jeffrey A. Keelan
Publikationsdatum
01.07.2004
Verlag
Springer International Publishing
Erschienen in
Clinical Pharmacokinetics / Ausgabe 8/2004
Print ISSN: 0312-5963
Elektronische ISSN: 1179-1926
DOI
https://doi.org/10.2165/00003088-200443080-00001